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ABSTRACT 
 
Forming and maintaining tubular structure is fundamental to organismal 
development.  The excretory canal cell of C.elegans forms a single-cell epithelial 
tubule, which provides a simple model for tubular structure study.  The EXC 
proteins regulate maintenance of the apical (lumenal) cytoskeleton of the 
excretory canal.  Loss of exc gene function allows formation of fluid-filled cysts 
in the excretory canal.  exc-9 mutants exhibit short and cystic canals compared to 
wild-type worms.  exc-9 mutants also exhibit tail defects in hermaphrodites and 
ray defects in male. 
By SNP mapping, cosmid rescue, and RNAi experiments, we proved that 
F20D12.5 encodes exc-9.  EXC-9 is a homologue of the mammalian intestinal 
LIM-domain protein CRIP.  exc-9 is highly expressed in the canal and tailspike, 
it is also expressed in some other cells, including UTSE, DTCs, and ALM neurons.  
Promoter regions important for exc-9 expression were studied.  It was found that 
EXC-9 functions cell-autonomously and the free N-terminus of the protein is 
required for unextended canal phenotype.  
Overexpression of exc-9 constructs in an N2 background sometimes 
causes an “unextended canal” phenotype, in which the canal forms a large cell 
body filled with lumen with proper diameter, but has no canals along the length of 
the animal.  Since canal extension is sensitive to expression levels of exc-9, 
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injection of the construct also caused unextended canal phenotype in exc-9 
mutants.  Similar unextended canal phenotype was also found in animals 
showing high levels of exc-5 expression.   
I used the unextended canal phenotype to examine epistasis of EXC-9 
function with that of other EXC proteins. EXC-9 appears to function upstream of 
EXC-5 to regulate cytoskeletal formation at the apical surface (possibly via 
CDC-42); and EXC-9 in turn may depend upon EXC-2 and EXC-4 function. 
A second well conserved CRIP homologue B0496.7 is highly expressed in 
multiple valves of C.elegans.  It functions similarly to EXC-9 when ectopically 
expressed in the excretory canal.  Expression of the mouse homologue CRIP in 
the canal failed to rescue exc-9 mutants, but with some modifications, mouse 
CRIP can function similar as EXC-9. 
Preliminary data of cloning of exc-2 is reported in this work too. 
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1.1 Introduction to Caenorhabditis elegans  
C. elegans is a soil dwelling nematode that has been used as a model 
organism for more than 40 years.  In 1965, Sydney Brenner chose C. elegans 
as a research model (Brenner, S. 1974), and began the era of C. elegans research.  
Since then, due to its transparency, short life cycle, small size, invariant cell 
lineage, fully sequenced genome and many other advantages, many scientists 
use it as their research model to study behavior, development, genetics, and cell 
biology. 
There are two sexes of C. elegans: male (XO) and self-fertilizing 
hermaphrodites (XX).  A hermaphrodite worm can produce about 300 progeny 
in its lifetime (Riddle, D.T., Blumenthal, T. et al. 1997).  From a fertilized egg 
to a fully developed adult worm will take approximately two days.  If supplied 
with enough food, the total lifespan for a worm is two to three weeks (Riddle, 
D.T., Blumenthal, T. et al. 1997).  Male frequency in a typical wild-type 
population is 0.1%.  When males mate with hermaphrodites, hermaphrodites 
will produce a 1:1 ratio of male and hermaphrodite cross-progeny (Riddle, D.T., 
Blumenthal, T. et al. 1997). 
C. elegans adult worms are about 1 millimeter in length and can be 
cultured on E. coli covered agar in a petri dish.  The dish can be checked under 
a dissecting microscope to examine obvious phenotypes.  Internal structure can 
be easily detected in vivo using a compound microscope because the worms are 
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transparent (Brenner, S. 1974). 
The complete genome sequence and predicted gene structure are 
available on wormbase (www.wormbase.org).  Wormbase provides this 
information in order to find possible target genes for cloning, and also helps to 
make reverse genetics feasible in C. elegans.   
All these advantages make C. elegans a great model for research. 
 
1.2 Epithelial structure 
An epithelium is a tissue composed of a layer of cells.  Epithelia line 
both the outside and inside cavities of the body, and separate the inside of an 
organism from the outside and also form barriers between two adjacent 
compartments.  Functions of epithelial cells include protection (e.g. skin), 
absorption (e.g. intestine), and secretion (e.g. kidney). 
Cell junctions are abundant in epithelial tissues, and are essential for 
selective permeability between two different environments on both sides of the 
barrier.  All epithelial structures have polarity (Fig. 1.2).  The apical surface 
faces the lumen or outside of the organism; the basal surface faces the basal 
lamina; the lateral surface is between the cells.  The apical surface is important 
for absorbing nutrients in the intestine and secreting waste in the kidney.  There 
are specializations on the apical surface of epithelial cells, e.g. microvilli, that 
increase the surface area, and cilia, that move or detect substances.  The 
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basolateral surface has junctions to maintain the polarity.  Tight junctions make 
adjacent cells adhere to each other.  They confine transport proteins to the 
appropriate membrane domains by acting as a barrier.  Gap junctions allow 
cells to communicate with one another.  Small molecules can pass through 
connexons.  The keratin intermediate filament networks connect adjacent cells 
through desmosomes and to the basal lamina through hemidesmosomes (see 
Fig.1.1). 
In C. elegans, the major epithelial tissues are: hypodermis, intestine, 
gonad, seam cells, excretory system and tail spike.  
 
1.3 Tubular structure 
Biological tubular structure is responsible for transport of vital fluids 
such as blood and liquid waste.  The formation of these tubes is critical for the 
majority of organisms.  In humans, most major organs such as kidney, lung and 
circulatory system are composed primarily or exclusively of tubes (Lubarsky, B. 
and Krasnow, M.A. 2003).   
There are multi-cell tubes and single-cell tubes.  The process of folding 
epithelial sheets is one method of forming multi-cell tubes.  Hollowing of a 
single cell leads to the formation of a single-cell tube.  Although they look and 
function differently, there are common aspects for both types of tubular structure: 
the inner lumen surface is apical-characteristic, and the outer surface of the tube is  
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Figure1.1  Diagram of epithelium cell with different kinds of junctions.  The 
junctions help epithelial structure to maintain the polarity.   
hemidesmosome  Basal lamina Basal surface 
Apical surface Tight junction 
Gap 
Desmosome 
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basal-characteristic (Buechner, M. 2002; Hogan, B.L. and Kolodziej, P.A. 2002; 
Lubarsky, B. and Krasnow, M.A. 2003).  
A recent model suggests that although tubes are different from each other, 
there is a common pathway for tubulogenesis.  During the process of cell cord 
hollowing, cell hollowing, or cavitation for tubular formation, the apical surface 
is expanded by means of vesicle fusion after the determination of the apicobasal 
polarity of the tube (Lubarsky, B. and Krasnow, M.A. 2003).  This conservation 
of mechanism implies that findings from the study of simple tubular networks on 
invertebrate model organisms may apply to the complex tubular organs of 
vertebrates. 
 
1.4 The Caenorhabditis elegans excretory system 
The excretory cell of Caenorhabditis elegans provides a genetic model 
of tubular development.  The excretory cell is the largest cell in C. elegans and 
also a major epithelium structure in the worm.  It functions to regulate 
osmolarity and internal hydrostatic pressure (Nelson, F.K., Albert, P.S. et al. 
1983; Buechner, M. 2002).   
The whole excretory system is composed of excretory cell, gland, duct, 
and pore cell.  The excretory canal cell body is located on the ventral side of 
the posterior bulb of the pharynx.  Two tubes form and extend right and left 
from the cell body to the lateral side of the worm.  These two tubes bifurcate 
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when they reach the lateral side and grow both anteriorly and posteriorly; the 
four tubes then form an H-shaped structure.  These processes make a seamless 
unicellular tube closed at its four endings (Nelson, F.K., Albert, P.S. et al. 1983; 
Nelson, F.K. and Riddle, D.L. 1984; Buechner, M. 2002).  The excretory canal 
is connected with the excretory duct; the collected fluid in the canal will pass 
through the duct to be excreted to the outside from the excretory pore cell.  
Fluids and wastes are collected into the arm of excretory cell and then excreted 
to the outside of the worm through the excretory duct.  The function of the 
excretory canal is analogous to that of the kidney (Nelson, F.K., Albert, P.S. et al. 
1983; Nelson, F.K. and Riddle, D.L. 1984; Buechner, M. 2002). 
The excretory system is required for worms to survive (Nelson, F.K. and 
Riddle, D.L. 1984; Buechner, M., Hall, D.H. et al. 1999).  After laser ablation 
of the excretory cells, the worms died in several hours (Nelson, F.K. and Riddle, 
D.L. 1984), likely due to the inability to get rid of liquid waste. 
 
1.5 exc mutants 
There are several genes that affect the formation of excretory canals.  
Mutations in thee genes disrupt the formation of the apical surface of the 
excretory canals; fluid-filled cysts are formed in the canal lumen in these 
mutants.  These mutants are called exc mutants, which stands for “excretory 
canal abnormal” (Buechner, M., Hall, D.H. et al. 1999).  Several exc genes 
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have been cloned.  A putative guanine nucleotide exchange factor, EXC-5, 
might work upstream of CDC-42 to direct new cytoskeleton to the apical 
membrane of the excretory canal (Gao, J., Estrada, L. et al. 2001; Suzuki, N., 
Buechner, M. et al. 2001).  The sma-1 gene encodes βH-Spectrin, which helps 
maintain the apical membrane structure (Praitis, V., Ciccone, E. et al. 2005).  
Let-653 encodes a secreted mucin that help to protect the exposed surface (Jones, 
S.J. and Baillie, D.L. 1995).  EXC-7 binds to the 3’UTR of the sma-1 mRNA, 
and is a nematode homologue of the Drosophila ELAV protein (Fujita, M., 
Hawkinson, D. et al. 2003).  EXC-4 is a chloride intracellular channel locates 
on the apical surface of the excretory canal.  How EXC-4 regulates the apical 
membrane structure of the excretory canal is not clear (Berry, K.L., Bulow, H.E. 
et al. 2003). 
 
1.6 exc-9 and exc-2mutants 
exc-9 and exc-2 are two genes that are also important for canal apical 
surface maintenance.  Mutations in either gene cause strong canal defects.  
Knowing the identity of these genes will help us to understand the whole 
pathway better. 
In my dissertation, I have mainly focued on the study of exc-9 cloning and 
characterization.  EXC-9 was found to be a single-LIM-domain protein. The 
mammalian homologue of EXC-9 is called CRIP (Cysteine rich intestinal 
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protein).  I showed that EXC-9 functions with several other EXC proteins to 
regulate the excretory canal structure. I also found out that the other C.elegans 
CRIP homologue could function in the similar way as EXC-9.
 10
 
 
 
 
 
 
 
 
Chapter 2 
Cloning of the exc-9 gene
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2.1 exc-9 mutants show a highly penetrant cystic phenotype 
exc-9 is a mutant named after its excretory canal defect.  Several obvious 
phenotypes of the exc-9 (n2669) mutants have been characterized.  All the 
defects are recessive. 
The most significant phenotype of exc-9 worms is the abnormal excretory 
canal.  The exc-9 mutants have wider and shorter canals, sometimes with septate 
fluid-filled cysts (Fig. 2.1C and 2.1D), while canals of wild-type N2 worms have 
fine lumena that run from head to tail (Fig. 2.1A and 2.1B).  The canal phenotype 
is not quite consistent from worm to worm, but it is 100% penetrant in 
homozygous animals (See Table 2.1), and it can be observed as early as the 2-fold 
stage.  13% of exc-9 mutants show very large cysts (Fig. 2.1D).  Due to 
impairment of this function, the worms with severe canal defects appear to have 
excess fluid and are sick. 
In addition to the canal defects, 40% of the exc-9 hermaphrodite mutants 
show tail defects (Fig. 2.1F) compared to the long pointed tailspike of wild-type 
worms (Fig. 2.1E).  Since the tailspike also is an epithelial structure and needs to 
maintain long projection shape, it might share some similar pathways of epithelial 
morphogenesis with the excretory canal.   
The tails of adult males are structurally different from hermaphrodites.  
They don’t have a tail spike, instead, form the sensory rays in the male tail that are 
still epithelial tissue.  In the exc-9 male mutants, approximately 40% of the
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Table 2.1 exc-9 cystic phenotype. 
 
Genotype %  cystic N (canal number) 
Wild type (N2) 0 100 
exc-9(n2669) 100 104 
exc-9(gk395) 100 119 
exc-9(n2669)/exc-9(gk395) 100 67 
+/ exc-9(n2669) 0 72 
+/ exc-9(gk395) 0 56 
exc-2(rh90)/ exc-9(n2669) 0 45 
exc-4(rh133)/ exc-9(n2669) 0 55 
exc-5(rh232)/ exc-9(n2669) 0 50 
 
“% cystic” shows the percentage of canals with abnormal excretory canal apical 
structure of the corresponding worms.  “N” stands for number of canals 
examined since two branches from the same excretory cell body develop 
independent from each other. 
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Figure 2.1 exc-9 mutant phenotypes. Anterior is to the left. Dorsal is on the top. (A) 
Schematic drawing of excretory canals in wild-type worm.  Blue line stands for 
canal tubes and orange part resemble the pharynx. (B) DIC micrograph of canal 
lumen in wild-type young adult. Black arrowheads indicate the canal lumen. The 
canals go all the way to near the tail of the worm as indicated by white arrowhead.  
(C, D)  exc-9 (n2669) mutants show cystic and shortened canals compared to 
wild-type worms. Some mutants have small cysts (C) and some mutants have a 
more severe cystic phenotype (D). This phenotype is 100% penetrant.  Black 
arrowheads indicate the lumen diameter and white arrowhead indicates the canal 
end in (C).  Black arrow points to the large cyst in (D).  (E) Tail whip in wild-type 
hermaphrodite tapers smoothly to a point.  (F) Tail whip of exc-9 (n2669) animal 
has poorly formed tip.  (G) Wild-type male has 9 sensory rays at one side of the tail, 
while exc-9 (n2669) animal (H) has malformed rays (indicated by white arrowhead) 
and fused rays (indicated by black arrow). (I) Wild-type hermaphrodite has small 
clear region next to the anal opening (black arrow).  (J) Black arrow indicates huge 
clear region around anal opening in exc-9 (n2669) mutant. Tail defects in exc-9 
(n2669) animals are about 40% penetrant.  Scale bar: 25µm.  
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worms show fewer rays or have an abnormal ray structure (Fig. 2.1H).  exc-9 
male worms show less mating efficiency.  Since the male rays are essential for 
sensing hermaphrodites, the less mating efficiency might be due to the abnormal 
ray structure.   
In addition to these phenotypes, exc-9 worms also show larger vacuole 
area around the anus.  Compared to the small clear region around the wild-type 
worm anus (Fig. 2.1I), 40% of the exc-9 mutants show a large clear region. This 
phenotype is similar to the swollen vacuoles of vha-8 mutants (Ji, Y.J., Choi, K.Y. 
et al. 2006).  The mechanism for this phenotype is not understood. 
 
2.2 exc-9 mapping 
Prior to my work, exc-9 was mapped to chromosome IV, between bli-6 and fem-3 
(Buechner, M., Hall, D.H. et al. 1999).  A Snip-SNP (single nucleotide 
polymorphism) mapping strategy was used to narrow down the region further (see 
Materials and Methods for details).  Double-mutant strains were constructed 
between exc-9 (n2669) and bli-6 (sc16) for the left side mapping (made by 
Matthew Buechner); and between exc-9 (n2669) and fem-3 (q22) for the right side 
mapping.  Then the double-mutants were crossed with the wild-type Hawaiian 
strain CB4856 to get recombinants for SNP site testing.  By means of SNP 
mapping, I narrowed the region of exc-9 in between SNP sites on cosmids C06A6 
and B0218, reducing the region of interest from 2.7 million base-pair to 340 kb 
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(Table 2.2 and Table 2.3).  Only thirteen cosmids available from the C. elegans 
sequencing consortium contain all the DNA covering in this region (Figure 2.2).   
Since RNAi is efficient in C. elegans to cause the post-transcriptional 
depletion of homologous endogenous RNA (Montgomery, M.K., Xu, S. et al. 
1998), RNAi was chosen to identify exc-9 at the beginning instead of Cosmid 
preparation and injection.   
Some candidate genes in the region were tested by means of RNAi to 
determine if they are exc-9 (Listed in Table 2.4).  Injection of sph-1 dsRNA plus 
a control marker, pCVC01, a repoter construct that expresses GFP in the canal 
(Oka, T., Yamamoto, R. et al. 1997), gave a cystic phenotype (5 out of 19 glowing 
progeny that have pCVC01 from injected N2 worms).  However, the control 
injection of pCVC01 alone found to cause cystic phenotype (7 out of 25 glowing 
progeny of PCVC01 injected N2 worm show abnormal canal), so an alternative 
marker pRF4, neomorph copy of the rol-6 gene, was tested.  The results 
indicated that pRF4 is a good injection marker to use for the canal phenotype 
because none of the 26 roller progeny from pRF4-injected N2 worms gave 
abnormal canals, and none of the 19 roller progeny from pRF4-injected exc-9 
(n2669) showed improved canals. 
The rest of the RNAi experiments were carried out using pRF4 as injection marker.  
None of the tested dsRNAs of candidate genes caused abnormal canal phenotype. 
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Table 2.2 Exc-9 non-Bli-6 SNP data. 
On the top are the SNP sites used to test the Exc-9 non-Bli-6 recombinants.  N2 
means the digestion pattern is the same as N2 worms and CB4856 stands for the 
same pattern as CB4856.  “\” means the strain was not tested for the specific 
SNP site. 
 
 
SNP sites tested  
 
Recombinant R05G6:2917 C06A6:2004 C49H3:3770 T09A12:14845 
1 N2 CB4856 \ \ 
2 N2 CB4856 \ \ 
3 N2 CB4856 \ \ 
4 N2 N2 CB4856 CB4856 
5 N2 CB4856 CB4856 CB4856 
6 N2 CB4856 \ \ 
7 N2 CB4856 \ \ 
8 N2 CB4856 \ \ 
9 N2 CB4856 \ \ 
10 N2 CB4856 \ \ 
11 N2 CB4856 \ \ 
12 N2 CB4856 \ \ 
13 N2 CB4856 \ \ 
14 N2 CB4856 \ \ 
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Table 2.3 Exc-9 non-Fem-3 SNP data. 
SNP sites tested Recombinant 
F20D12:32689 B0218:15870 T09A12:14845 D2096:39721 
I \ N2 CB4856 CB4856 
II \ N2 CB4856 CB4856 
III \ N2 CB4856 CB4856 
IV \ N2 CB4856 CB4856 
V \ N2 N2 CB4856 
VI \ N2 CB4856 CB4856 
VII N2 CB4856 CB4856 CB4856 
VIII \ N2 CB4856 CB4856 
On the top are the SNP sites used to test the Exc-9 non-Fem-3 recombinants.  N2 
means the digestion pattern is the same as N2 worms and CB4856 stands for the 
same pattern as CB4856.  “\” means the strain was not tested for the specific 
SNP site. 
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Figure 2.2 Genetic map of exc-9 cloning and exc-9 gene structure.  exc-9 
was mapped in between bli-6 and fem-3  on linkage group IV.  By SNP mapping, 
the region was narrowed down between SNP sites C06A6:2004 and B0218:15870.  
There are 13 cosmids in this region.  Injection of cosmid F20D12 can rescue exc-9 
phenotype.  There are seven genes in this cosmid and knockdown of gene 
F20D12.5 in wild-type background showed a similar phenotype as exc-9 mutants.  
The green boxes stands for the exc-9 (F20D12.5) exons and the lines in between 
stand for the introns.  The mutations in exc-9 alleles and RNAi fragment design are 
indicated in the gene structure. 
RNAi fragment
n2669 Amber mutation// 
  
gk395  966bp deletion
LG I V   
bli - 6  fem - 3  
3.19mu  4.05mu  
B0218:15870 C06A6:2004 
C06A6  C49H3 F53A12 C26B2 F42G8  
F20D12 C55F2  B0218  Y42H9B Y42H9AR 
F 20D12.3   
F20D12.7   
F20D12.5 
F20D12.4 
F20D12.2 F20D12.1 
F20D12.6 
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Table 2.4 exc-9 candidate genes in the refined region. 
Name Gene Identity 
C49H3.1 
 
gcy-8 receptor-type guanylyl cyclase 
C49H3.8 -- actin-like protein 
F42G8.11 sph-1 synaptic vesicle channel protein 
B0218.8 -- contains similarity to Pfam domain PF00059 
(Lectin C-type domain short and long forms) 
The genes with possible role in cytoskeleton organization were selected as RNAi 
target to test whether they are exc-9. 
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2.3 Cosmid rescue 
The cosmids in the refined region were purified and injected into n2669 
worms to see if they could rescue the exc mutant phenotype.  Plasmid pRF4 was 
used as co-injection marker. 
For the injection of cosmid F20D12, n2669 with roller phenotype showed 
almost perfect canal phenotype (Fig. 2.3A, Table 2.5).  
For the injection of other cosmids in the region into n2669, none of the 
progeny with roller phenotype showed perfect canals (See Table 2.5).   
 
2.4 Identifying the exc-9 gene 
Cosmid F20D12 was shown possibly to contain exc-9, but there are seven 
genes in this cosmid.  To find out which gene is exc-9, RNAi experiments were 
done for each of the genes.  pRF4 was used as co-injected as marker (see 
Materials and Methods for details).  Only when injected with double-stranded 
RNA complementary to the F20D12.5 gene (Fig.2.2) into wild-type worms, did 
roller progeny show an abnormal excretory canal phenotype similar to exc-9 
mutants (6 out of 23 roller worms) (Fig. 2.3B).  In some roller progeny, the tail 
structure was affected, showing similar deformed tails as do exc-9 mutants (Fig 
2.3C). This indicates that F20D12.5 is the gene that encodes exc-9. 
To confirm this, I tested whether smaller fragments from the cosmid that contain 
only F20D12.5 could rescue exc-9 or not.  Cosmid F20D12 was cut into  
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Table 2.5 Cosmid preparation and injection. 
* “Enzyme” is referring to the enzymes used to cut the cosmids in the exc-9 
region to test whether the cosmids are intact or not.  The numbers for the “roller 
progeny” are the numbers of progeny with injection marker. 
 
Cosmid Enzyme*  Roller progeny rescue 
C06A6 ApaLI \ \ 
T06C10 PstI \ \ 
C55F2 PstI \ \ 
C49H3 XbaI \ \ 
F20D12 FspI 30 5 out of 30
C18F3 XbaI \ \ 
C26B2 EcoRV \ \ 
F42G8 SacI,EcoRV, XbaI 15 No 
Y7B5 (including 
F42G8, B0218) 
 7 No 
F35H10 XhoI 10 No 
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Figure 2.3 F20D12.5 encodes exc-9. (A) Canal in progeny of exc-9 (n2669) 
animal microinjected with F20D12.5 cosmid DNA.  Canal lumen is restored to 
normal diameter (black arrowheads), and extends all the way to the tail.  The tail 
whip phenotype is normal too.  dsRNA (364 bp) corresponding to the exc-9 2nd 
and 3rd exons was injected into wild-type worms.  Progeny shows wider canals 
(B) and malformed tail whips (C), similar to the phenotype of exc-9(n2669) 
mutants.  Scale bar: 50μm.  
C 
B 
A 
 24
three pieces using restriction enzyme FspI.  Injection of a 11Kb fragment that 
contains the whole F20D12.5 coding region with promoter into n2669 worms 
improved canal defects in the mutant background (4 out of 17 worms).  A PCR 
fragment containing 2.2Kb of promoter and predicted coding region of F20D12.5 
was made and also injected into n2669 mutants.  This construct rescued the exc-9 
mutant canal phenotype as well (4 out of 21 worms). 
To determine where the mutation is in the F20D12.5 gene, I amplified this 
gene from n2669 worms and sequenced through the predicted exc-9 coding region.  
I found a C to T base-pair change in exon 3 on the sense strand, which is predicted 
to create an amber mutation (Fig. 2.2).  This mutation would make the protein 
30% shorter, and destroy the only identified conserved domain, LIM domain, in 
the EXC-9 protein.   
We obtained a knockout strain VC976 (gk395) from the CGC with a large 
deletion of gene F20D12.5. The first two exons and part of the promoter of gene 
F20D12.5 is deleted in this allele (Fig. 2.2).  Worms with allele gk395 shows a 
similar extent of excretory canal defects as does allele n2669, and gk395 failed to 
complement allele n2669; the heterozygotes had similar canal defects as did the 
two parental alleles (see Table 2.1).  These data confirm that the gene F20D12.5 
is exc-9, and indicates that allele n2669 is likely a null allele, as is gk395. 
 
2.5 cDNA analysis of exc-9  
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5’-RACE and 3’-RACE were done to determine the complete mRNA 
sequence of exc-9.  I confirmed that the predictions of the coding region from 
Wormbase is accurate and found that an SL1 leader sequence is spliced onto 5’end 
of the exc-9 mRNA. 
 
2.6 Tissue-specific expression of exc-9 
Another way to confirm the cloning data is the expression pattern of the 
cloned gene.  To determine the expression pattern of exc-9, a GFP (Green 
Fluorescent Protein) reporter construct was made.  The transcriptional GFP 
reporter for exc-9 expression, called Pexc-9::gfp (pBK104) was made by fusing 
2.2kb of exc-9 upstream sequence to the 5’ end of the gfp coding region (Fig.2.4).  
The Fire vector pPD95.75 was used as backbone of this construct.  
This construct was injected into wild-type worms to generate transgenic 
line carrying the extrachromosomal array of pBK104.  The transgenic line 
showed expression of GFP in the excretory cell, the UTSE (uterus seam cell), tail 
spike, distal tip cell, ALM neuron, and PLN neuron (Fig.2.5).  We also detected 
intestinal expression of GFP. 
A translational GFP construct was made as well.  2.2kb upstream region 
of exc-9 plus the whole exc-9 genomic coding region (exons and introns, but no 
stop codon) was fused to the 5’ end of gfp coding region in the backbone of 
pPD95.75.  The coding region of exc-9 is in frame with that of GFP (Fig. 2.4).  
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pBK104 
pBK121 
exc-9 coding region 
exc-9 2.2kb promoter 
GFP coding region 
Figure 2.4 exc-9 GFP construct structures.  pBK104 is the transcriptional construct, 
and pBK121 is the translational construct.  Both constructs have the 2.2 kb exc-9 
proter.  pBK104 has the gfp coding region following the promoter.  The promoter is 
followed by exc-9 coding region and in-framed gfp coding region in pBK121. 
1kb 
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Figure 2.5 exc-9 expression pattern. exc-9 GFP reporter construct with the 2.2kb 
promoter region was found in the excretory canals (A) (as indicated by white 
arrowheads), and tail whip (B) that are affected in the mutants. exc-9 is also 
expressed in the anchor cell (C), uterine seam cell (D), distal tip cells(E), and ALM 
neurons (A) indicated by white arrow.  The GFP expression is not found in the 
male sensory rays indicated by white arrow (F), but is expressed in the male tail 
whip at an early stage of development (G).  Anterior is to the left in all the pictures.  
Scale bars, 50 µm.   
 
A B 
C D 
E 
G F 
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This construct is termed Pexc-9::exc-9::gfp (pBK121).  This construct was also 
introduced into wild-type background by means of injection, yielding a transgenic 
line carrying an extrachromosomal array of pBK121.  This line showed the same 
expression pattern of GFP as did the transgenic line carrying the transcriptional 
construct pBK104. 
To determine whether this translational construct was capable of rescuing 
the exc-9 mutant phenotype, the construct was injected into exc-9 (2669) mutant 
worms.  All the progeny with excretory canal GFP expression showed an 
improved canal phenotype (See Chapter 3, Table 3.4, Fig. 3.6 and Fig. 3.7). 
Since both excretory canal and tail spike are affected in exc-9 mutant 
background, and both of them showed exc-9 expression, we wondered whether 
UTSE is affected in the exc-9 background since it has EXC-9 expression as well.  
This examination was done by the laboratory of Dr. Wendy Hanna-Rose (Penn. 
State University, personal communication), who found that the UTSE does not 
appear to be affected in exc-9 mutant background.   
 
2.7 Expression pattern in male worms 
The expression of the construct in male worms is similar to that in the 
hermaphrodite.  The GFP expression was found in the excretory canal and 
neurons.  Since male worms do not have a UTSE, it was not surprising that no 
GFP expression was found in the midsection of the body. 
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As mentioned earlier, male exc-9 mutants show ray defects.  Based on 
hermaphrodite expression pattern, I thought that the transcriptional construct 
expression would be found in the ray structure, just as EXC-9 expressed in the 
hermaphrodite tail spike. 
To my surprise, EXC-9::GFP expression was not found in the ray structure.  
In early stages before the male tail developed completely, the tail structure of male 
is similar to that of the hermaphrodite.  At those stages, GFP expression could be 
detected in the tail spike (Fig. 2.5G).  When the tail was fully developed, 
however, the GFP expression disappeared from the region (Fig. 2.5F).  This 
result suggests that ray structure maintenance once the rays are formed does not 
require the presence of EXC-9.  But it is required to be in the tail to give some 
signals for proper male tail development in early stages. 
 
2.8 Summary 
exc-9 mutant worms show 100% penentrant canal defect.  I used 
Snip-SNP mapping strategy narrowed down the region of this gene.  By cosmid 
rescue, RNAi injection, complementation test, sequecing mutant and examing the 
expression pattern of the gene, I confirmed that gene F20D12.5 is exc-9. 
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Chapter 3 
Characterizing the EXC-9 protein 
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3.1 exc-9 encodes a single LIM domain protein 
exc-9 encodes a small 85AA (amino acid)-protein.  By using BLAST, 
CRIP (Cysteine rich intestinal protein) was found as the most closely related 
homologue.  Mouse CRIP1 and EXC-9 share 62.8% identity and 72.1% 
similarity.  The mouse CRIP1 is highly expressed in the intestine, and named 
because of this.  Human CRIP1 is also known as CRHP (Cysteine rich heart 
protein) or CRP1 (Cysteine rich protein1).  It has high expression levels in both 
intestine and heart in humans.  This human homologue shows 74.4% identity and 
62.8% similarity to EXC-9.  In addition to the CRIP1 protein, mammals also 
have another LIM-domain-containing protein called CRIP2.  This protein 
resembles two CRIP1 proteins that are stitched together.  There also is a leech 
homologue that shows high similarity to EXC-9.  Each of these homologues 
show high similarity in the N-terminal conserved LIM domain, but they all have 
shorter C-terminus than does EXC-9, although the C-terminus still show 
homology among these proteins.  In addition to all these homologues in other 
organisms, there is another CRIP homologue in nematode.  The locus of the 
corresponding gene in C. elegans is B0496.7.  Compared to other EXC-9 
homologues, protein B0496.7 shares much higher similarity in the unique 
C-terminus with EXC-9; overall it shows 81.2% identity and 88.2% similarity 
(Fig. 3.1 and Fig. 3.2). 
The mouse homologue was shown to be important for Zn transport in 
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Figure 3.1 exc-9 encodes the C. elegans CRIP homologue. (A) Schematic drawing 
of EXC-9 protein. (B) Clustal-W alignment of the EXC-9 protein to homologues. 
There is a paralogue B0496.7 in C. elegans that shows as high a similarity to 
exc-9 as do other CRIP proteins. The underlined part is the LIM domain of EXC-9 
protein.  CBG proteins are the proteins from C. briggsae. 
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Figure 3.2 Phylogenetic tree of EXC-9.   
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intestine by in vitro experiment and is negatively regulated by metallothionein 
(Escobar, O., Sandoval, M. et al. 1995).  Coursins and coworkers showed that 
mouse CRIP  affects the immune response when overexpressed (Cousins, R.J. 
and Lanningham-Foster, L. 2000; Lanningham-Foster, L., Green, C.L. et al. 2002).  
CRIP in leech (Hirudo Medicinalis) stimulates neuron regeneration when 
overexpressed (Emes, R.D., Wang, W.Z. et al. 2003; Blackshaw, S.E., Babington, 
E.J. et al. 2004).  Human CRIP was shown to have elevated expression in breast 
cancer cells (Ma, X.J., Salunga, R. et al. 2003), but is down-regulated in 
esophageal squamous cell carcinoma (Yamashita, K., Upadhyay, S. et al. 2002).   
The homologues of EXC-9 didn’t give obvious information about how 
EXC-9 regulates the apical surface of the excretory canal.   
 
3.2 EXC-9 functions cell-autonomously 
As mentioned in Chapter 2, injection of pBK121 (Pexc-9::exc-9::gfp)  
into the exc-9 background improves the canal phenotype, makes the canal longer 
and cysts shorter.  Since the construct is an extrachromosomal array, the GFP 
expression is not as stable as are integrated arrays.  Occasionally, the GFP 
expression in some tissues will be lost in the progeny.  For the glowing worms 
that lost the construct’s expression in the canal, 45% of them showed large cysts 
(n=20), but none of the worms with canal expression of GFP showed any large 
cysts (n=41, Table 3.4).  The result suggests that EXC-9 is required to be present 
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Table 3.1 Canal phenotype of exc-9 (gk395) worms. 
 
 
Length of the posterior canal are shown by showing the location of ending point.  There 
are five catergories as shown in the figure above.  Cyst size is also categorized as five 
levels: “N” for no cyst, “T” for tiny cyst of which the diameter is almost the same as 
canal diameter, “S” for small cyst that has diameter less than one quarter of the worm 
diameter, “M” for medium cyst of which the diameter is less than half of the worm 
diameter but larger than half of that, “L” for large cyst that has diameter larger than half 
of the worm diameter.  Total number of canal screened is shown in the right bottom cell 
of the table.  All the canal phenotype data table in the thesis are shown in the same way. 
 
Table 3.2 Canal phenotype of F1 generation of exc-9 (gk395) injected with 
pBK122. 
 
 
 
0 1 2 3 4 
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Figure 3.3 Canal ending point in exc-9 (gk395) worms with or without pBK122.  
Diagramed using the data from Table 3.1 and Table 3.2. 
 
 
Figure 3.4 Canal cyst size in exc-9 (gk395) worms with or without pBK122.  
Diagramed using the data from Table 3.1 and Table 3.2.
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in the canal to maintain the tubular structure.  
To determine whether canal expression of exc-9 is sufficient for rescue of 
the exc-9 mutant phenotype, I made a construct (pBK122) that expresses exc-9 
mainly in the canal.  This construct has the vha-1 promoter that drives gene 
expression mainly in the excretory canal.  The genomic coding region of exc-9 
was fused downstream of the vha-1 promoter and followed by GFP coding region 
in-frame (Fig. 3.10). The injection of this construct into the exc-9 background 
showed GFP expression in the canals but not in the tailspike, and it rescued the 
exc-9 cystic canal phenotype, but not the tail spike phenotype.  64% of the 
glowing worms still exhibited various extent of tail defects (n=47).  Since this 
construct is not expressed in the tail spike, it is consistent with the rescue result. 
In summary, EXC-9 protein function cell-autonomously in the canals.  It 
is required to be expressed in the canal and expression solely in the excretory cell 
is sufficient to maintain the small diameter of the canals. 
 
3.3 Overexpression of EXC-9 causes a new canal phenotype 
Overexpression pBK121 (Pexc-9::exc-9::gfp) causes a phenotype similar 
to that caused by overexpression of exc-5 translational construct (Suzuki, N., 
Buechner, M. et al. 2001).  After injection of pBK121 into exc-9 worms, some of 
the progeny with brighter GFP expression showed normal diameter canals, but the 
canals didn’t extend to the posterior part of the worms.  Instead, the canals  
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Figure 3.5 Over-expression of a translational exc-9::gfp fusion construct (pBK121) 
causes a new phenotype similar to the over-expression of an exc-5 translational 
construct (Suzuki, N., Buechner, M. et al. 2001) in both exc-9 and wild-type 
backgrounds; we call this phenotype an “unextended” canal. (A) In a wild-type 
worm containing the over-expression construct, the canal lumen diameter is normal, 
but the canals can’t extend to the posterior.  The lumen, indicated by black arrow, 
is rolled up inside the cell body.  The tail whip is sometimes distorted also (B).  
The anterior is to the left in the pictures.  Scale bar: 25µm 
A 
B 
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Table 3.3 Canal phenotype of exc-9 (n2669) worms.  
 
 
 
 
 
Table 3.4 Canal phenotype of F1 generation of exc-9 (n2669) injected with 
pBK121 
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Figure 3.6 Canal ending point in exc-9 (n2669) worms with or without pBK121.  
Diagramed using the data from Table 3.3 and Table 3.4. 
 
Figure 3.7 Canal cyst size in exc-9 (n2669) worms with or without pBK121.  
Diagramed using the data from Table 3.3 and Table 3.4. 
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Table 3.5 Canal phenotype of N2 worms.  
 
 
 
 
 
 
Table 3.6 Canal phenotype of F1 generation of N2worm injected with pBK121. 
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Figure 3.8 Canal ending point in N2 worms with or without pBK121.  Diagramed 
using the data from Table 3.5 and Table 3.6. 
Figure 3.9 Canal cyst size in N2 worms with or without pBK121.  Diagramed 
using the data from Table 3.5 and Table 3.6. 
N2 canal length
0
20%
40%
60%
80%
100%
120%
cell body <vulva around Vulva >vulva full length Unextended
canal
canal  length
pe
rc
en
ta
ge
N2 (n=100)
N2 w/exc-9(n=44)
pe
rc
en
ta
ge
N2 cyst size
0
20%
40%
60%
80%
100%
120%
L M S N 
cyst size
pe
rc
en
ta
ge
N2(n=100) 
N2 w/exc-9(n=44)
pe
rc
en
ta
ge
 43
 circled inside the canal cell body (Fig. 3.5A).  I called this phenotype 
“unextended canal”.   
To determine if unextended canals occurred only in the exc-9 background, 
the same construct was injected into N2 worms.  A similar unextended 
phenotype was observed in these animals (Table 3.6, Fig. 3.8).  N2 worms with 
unextended canal also occasionally had abnormal tail spike (Fig. 3.5B). 
These results suggest that the canal extension and tail spike assembly are 
sensitive to the copy number of the exc-9 gene.  To ensure that this phenotype 
was caused by high levels of the EXC-9 protein, the transgenic N2 line with 
pBK121 was fed on a GFP RNAi feeding plate.  As the level of EXC-9::GFP 
was reduced, animals with unextended canals were increasingly difficult to find.  
This result indicated that the unextended canals are caused by overexpression of 
exc-9. 
 
3.4 A free N-terminus is essential for unextended canal phenotype 
Injection of construct pBK122 (Pvha-1::exc-9::gfp) rescued cystic canal 
defects of exc-9 mutants, but the unextended canal phenotype was not observed in 
any of the glowing progeny (Table 3.4, Fig. 3.6).  After inspection, I found out 
that the endogenous start codon of vha-1 is in the plasmid pBK122, and it is 
in-frame with the exc-9 coding region.  The chimeric protein translated from this 
construct has eleven extra amino acids at the N-terminus (Fig. 3.10).  These extra 
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amino acids may reduce EXC-9 activity and explain why no worms with 
unextended canal were found. 
To prove this hypothesis, a new construct was made.  The vha-1 
endogenous start codon was cut out from the pBK122 along with the vha-1 
promoter.  Then the amplified vha-1 promoter alone was ligated back to the same 
backbone.  From this construct, the product should be a protein with the 
complete EXC-9 followed by GFP.  This construct is named pBK130 (Fig. 3.10). 
I injected this construct into exc-9 mutants, and screened for canal 
phenotypes in the progeny.  I found progeny with glowing canals showed 
unextended canal phenotypes (Table3.7, Fig. 3.11).   
These results indicate that extra amino acids partially impaired the 
function of the EXC-9 N-terminus.  Without the free N-terminus, EXC-9 protein 
could function to maintain the canal structure.  But only when the free 
N-terminus is unblocked, the canals could respond to the excess amount of EXC-9 
and fail to extend to the posterior, form the unextended canals. 
 
3.5 EXC-9 and CSN-5 physically interact in a yeast two-hybrid assay 
It is proposed that LIM domain proteins function by binding with other 
proteins (Kadrmas, J.L. and Beckerle, M.C. 2004).  To find out the possible 
binding partner of EXC-9, a yeast two-hybrid assay was chosen to fulfill this goal. 
The cDNA of exc-9 was purified and sent to the Molecular Interaction 
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Figure 3.10 Structure of vector pBK122 and vector pBK130.  both constructs 
have vha-1 promoter and exc-9, gfp coding region.  The difference is that 
pBK122 has eleven extra amino acids at the N-terminus start from vha-1 
endogenous start codon (brown block). 
pBK122 
vha-1 promoter GFP coding region exc-9 coding region 
pBK130 
vha-1 promoter exc-9 coding region GFP coding region 
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Table3.7 F1 generation of exc-9 (gk395) animals injected with pBK130. 
 
 
 47
 
Figure3.11 Canal ending point in exc-9 (gk395) worms with or without pBK130.  
Diagramed using the data from Table 3.1 and Table 3.7. 
Figure3.12 Canal cyst size in exc-9 (gk395) worms with or without pBK130.  
Diagramed using the data from Table 3.1 and Table 3.7.
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Facility of University of Wisconsin, Madison for a yeast two-hybrid assay with 
other C. elegans genes. 
The exc-9 complete cDNA was ligated into bait vector.  The prey library 
was made from RNA isolated from mixed stage C. elegans hermaphrodites.  The 
screen was conducted at low stringency to maximize the chance to find even weak 
interactors.  Approximately 36 million clones were screened via mating.  Five 
putative interactors were isolated with the exc-9 bait.  One of the colonies was 
eliminated as a false positive because of its ability to interact with the empty bait 
vector.  After sequencing, all the other four validated prey turned out to be csn-5, 
which is a C. elegans COP-9 SigNalosome subunit family member.  The COP-9 
SigNalosome is involved in protein degradation. 
A loss of function mutant strain of csn-5 was then acquired from the CGC.  
The strain VC861 csn-5 (ok1064) IV/ nT1 122(IV; V) didn’t show any canal 
defects (n>100).   
To determine whether the lack of canal defects is because the strain is 
heterozygous, dsRNA complementary to csn-5 was made and injected into N2 
worms, with pRF4 as marker.  None of the roller progeny showed any canal 
defects (n=35). 
Another approach was to find out whether csn-5 is expressed in the canal.  
The promoter of csn-5 was amplified and ligated into the pPD95.75 vector.  No 
GFP expression was detected in the canal or any other tissues with exc-9 
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expression.  
The studies of csn-5 in C. elegans suggest that CSN-5 does not work with 
EXC-9, which conflicts with the yeast two-hybrid data.  Since CSN-5 shows 
strong affinity with EXC-9 in the yeast two-hybrid experiment, it is possible that 
these two proteins have potential to bind with each other.  Because they don’t 
have an overlapping expression pattern, they don’t bind with each other in vivo.  
 
3.6 EXC-9 antibody work 
EXC-9 antibodies were made by Sigma-Genosys (The Woodlands, TX).  
One antibody is against a synthetic peptide from the mid region of the LIM 
domain, and the other is a synthetic peptide from the end of the LIM domain and 
part of the C-terminus region  (Fig. 3.13).   
Wild-type and mutant worm extracts were isolated from N2 and exc-9 
(n2669) worms.  A western blot was carried out.  In the western blot, a 
difference was found between exc-9 and N2 worm.  N2 worms show a band at 
around 20KD, which is lacking or less abundant in the exc-9 lanes (Fig. 3.14).  
This size is about double the size expected for EXC-9, which is 9.5KD.   
We speculated whether this is because EXC-9 forms a homo-dimer 
through cysteine in the worm.  Since the dimer will have a similar structure as 
mammalian CRIP2, the dimer might function similarly to CRIP2 as well.  The 
reason I saw a dimer size instead of monomer size on the film might be
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Figure 3.13 Antibody design of EXC-9.  The underlined part is the LIM domain.  
Antibodies 14649 and 14650 are against the peptide highlighted in yellow.  
Antibodies 14651 and 14652 are against the peptide highlighted in magenta.  The 
amino acid in white is mutated in allele n2669. 
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Fig 3.14 Western blot gel picture.  White arrowheads indicate the different 
band in N2 lanes.  The sample names are listed on the top and the seraum 
names are listed on the bottom of the blot. 
  N2    exc-9     N2   exc-9     N2     exc-9     N2     exc-9             
      14651                            14650                               
immunized serum    14651       immunized serum          14650           
                   preimmune serum                     preimmune serum      
50KD 
25KD 
29KD 
10KD 
15KD 
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because disulfide bonds were not broken completely in the SDS PAGE gel.  
Another possible reason is that these two antibodies are not specific enough.  
I performed the worm staining four times using these two antibodies on 
both N2 and exc-9 (n2669) worms.  Intestinal staining was detected but 
none of the strains showed excretory canal specific staining.  It didn’t 
exclude the possibility that the canals are narrow and don’t show antibody 
staining as well since SMA-1 antibody didn’t stain the canal either 
(personal communication). 
 
3.7 Conclusion  
EXC-9 translational construct not only rescues exc-9 mutant phenotype, it 
also causes a new phenotype called “unextended canal” when overexpressed.  
Canal specific expression of EXC-9 suggests that the protein function 
cell-autonomously and the unblocked N-terminus is important for the “unextended 
canal” phenotype. 
CSN-5 was pulled out as a binding partner of EXC-9 in yeast two-hybrid 
assay.  But study of mutant phenotype and expression pattern didn’t support they 
bind to each other in vivo.
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Chapter 4 
Genetic interactions between exc-9 and other exc genes 
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4.1 overexpression of exc-9 in other exc backgrounds 
As mentioned in Chapter 3, overexpression of an exc-9 translational 
construct (pBK121) causes unextended canals in both exc-9 mutant and wild-type 
backgrounds.  We want to test whether this construct could cause a similar 
phenotype in the background of other exc mutants as well.   
If this construct could cause similar phenotype in a mutant background, it 
is possible that EXC-9 works downstream of this protein; if not, the protein  
might function downstream of EXC-9 to control the canal diameter.  If there is 
no reciprocal rescue, it is possible that the two proteins function in parallel 
pathways. 
Since all the exc mutants have 100% penetrance canal defect, I checked 
whether the canal phenotype of those exc mutants got improved or not with the 
injection of exc-9 translational construct. 
 
4.2 Injection of pBK121 into exc-4 background 
EXC-4 is a C. elegans chloride intracellular channel homologue (Berry, 
K.L., Bulow, H.E. et al. 2003).  It has been shown by means of heat-shock 
experiment that function of this gene in early stages of worm development is 
essential for normal canal structure (Berry, K.L., Bulow, H.E. et al. 2003).  How 
EXC-4 regulates the excretory canal structure is not clear.  It has been proposed 
that EXC-4 likely helps to acidify the fusing compartments, and in turn helps to  
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Table 4.1 Canal phenotype of exc-4 (rh133) worms. 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2 Canal phenotype of F1 progeny of exc-4 (rh133) injected with pBK121. 
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Figure 4.1 Canal ending point in exc-4 (rh133) worms with or without 
pBK121Diagramed using the data from Table 4.1 and Table 4.2. 
 
Figure 4.2 Canal cyst size in exc-4 (rh133) worms with or without pK121.  
Diagramed using the data from Table 4.1 and Table 4.2. 
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Figure 4.3 exc-4 mutant worms with or without exc-9 translational construct.  (A) 
An exc-4 (rh133) mutant that showed large cysts next to the pharynx.  (B) An exc-4 
(rh133) with pBK121 (exc-9::gfp) construct showed unextended canal instead of 
cystic canal (indicated by white arrow). 
 
A 
exc-4 
exc-4/pBK121 
B 
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maintain the canal structure, or it may control canal diameter by regulating water 
transport (Berry, K.L., Bulow, H.E. et al. 2003). 
Injection of pBK121 into exc-4 (rh133) worms improved the canal defects 
of the mutants in F1 generation, and some worms with unextended canal 
phenotype were found (Table 4.1, Table 4.2 and Fig. 4.1, 4.2).  In the transgenic 
line of exc-4 (rh133) worms carrying pBK121, almost 100% of the glowing 
worms showed unextended canals, as seen in Figure 4.3.  The reason for this 
difference between F1 generation and stable line might be due to maternal effect 
in the transgentic line. 
 
4.3 Interactions between exc-5 and exc-9 
EXC-5 is a putative guanine nucleotide exchange factor of CDC-42 (Gao, 
J., Estrada, L. et al. 2001; Suzuki, N., Buechner, M. et al. 2001).  EXC-5 is a 
homologue of human FGD1, which plays an important role in skeletal formation 
(Gao, J., Estrada, L. et al. 2001).  Overexpression of EXC-5 also causes the 
unextended canal phenotype (Suzuki, N., Buechner, M. et al. 2001).  Since exc-5 
and exc-9 mutants have similar phenotypes and overexpression of respective 
translational constructs caused a similar unextended canal phenotype, it is likely 
that these two genes work in the same pathway. 
Injection of a exc-9 translational construct into exc-5 (rh232) didn’t create 
any unextended canal worms or improve the canal phenotype (Table 4.3 and Table  
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Table 4.3 Canal phenotype of exc-5 (rh232) worms. 
 
 
Table 4.4 Canal phenotype of F1 progeny of exc-5 (rh232) injected with pBK121. 
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Figure 4.4 Canal ending point in exc-5 (rh232) worms with or without 
pBK121.Diagramed using the data from Table 4.3 and Table 4.4.   
 
Figure 4.5 Canal cyst size in exc-5 (rh232) worms with or without pBK121.  
Diagramed using the data from Table 4.3 and Table 4.4.   
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Table 4.5 Canal phenotype of exc-9 (gk395) worms. 
 
 
 
 
 
 
Table 4.6 Canal phenotype of F1 progeny of exc-9 (gk395) injected with pBK121. 
 
 
Table 4.7 Canal phenotype of F1 progeny of exc-9 (gk395) worms injected with 
Pexc-5::exc-5::gfp. 
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Figure 4.6 Canal ending point in exc-9 (gk395) worms with or without pBK121, and 
with Pexc-5::exc-5::gfp.  Diagramed using the data from Table 4.5, 4.6 and 4.7.   
 
Figure 4.7 Canal cyst size in exc-9 (gk395) worms with or without pBK121, and 
with Pexc-5::exc-5::gfp.  Diagramed using the data from Table 4.5, 4.6 and 4.7.   
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4.4, Fig4.4 and Fig 4.5). On the other hand, injection of a exc-5 translational 
construct into exc-9 (gk395) caused a high percentage of unextended canals 
(Table4.5, Table4.6, Table4.7, Fig4.6 and Fig 4.7). 
 
4.4 Injection of pBK121 into exc-2 background 
exc-2 has not been identified.  The exc-2 mutant is one of the sickest exc 
mutants.  Over 40% of the exc-2 worms show large cysts in the canal, larval 
lethality was observed in exc-2 mutants.  Injection of pBK121 into exc-2 mutants 
greatly improved the canal defects in the progeny.  The percentage of worms 
with large cyst dropped dramatically (Table4.8 and Table 4.9; Fig.4.8 and Fig 4.9).  
These suggest that EXC-9 functions downstream of EXC-4. 
 
4.5 sma-1 worms with exc-9 
The sma-1 gene encodes βH-Spectrin that is locate on the apical membrane 
of the excretory canal (Praitis, V., Ciccone, E. et al. 2005).  To our surprise, exc-9 
construct could partially rescued sma-1 mutants (Table4.10 and Table 4.11; 
Fig.4.10 and Fig.4.11).   Indicates that exc-9 plays a role downstream of sma-1. 
 
4.6 Injection of pBK121 into exc-1 worm 
exc-1 is another uncloned gene.  After injection with exc-9 translational construct 
into parents, the progeny with glowing canals didn’t show any improvements  
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Table 4.8 Canal phenotype of exc-2 (rh90) worms. 
 
 
Table 4.9 Canal phenotype of F1 progeny of exc-2 (rh90) injected with pBK121. 
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Figure 4.8 Canal ending point in exc-2 (rh90) worms with or without pBK121.  
Diagramed using the data from Table 4.8 and Table 4.9.   
 
Figure 4.9 Canal cyst size in exc-2 (rh90) worms with or without pBK121.  
Diagramed using the data from Table 4.8 and Table 4.9.   
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 Table 4.10 Canal phenotype of sma-1 (ru18) worms. 
 
 
Table 4.11 Canal phenotype of F1 progeny of sma-1 (ru18) injected with pBK121. 
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Figure 4.10 Canal ending point in sma-1 (ru18) worms with or without pBK121.  
Diagramed using the data from Table 4.10 and Table 4.11.   
 
Figure 4.11 Canal cyst size in sma-1 (ru18) worms with or without pBK121.  
Diagramed using the data from Table 4.10 and Table 4.11. 
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Table 4.12 Canal phenotype of exc-1 (rh26) worms. 
 
 
 
 
 
 
 
Table 4.13 Canal phenotype of F1 progeny of exc-1 (rh26) injected with pBK121. 
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Figure 4.12 Canal ending point in exc-1 (rh26) worms with or without pBK121.  
Diagramed using the data from Table 4.12 and Table 4.13.   
 
Figure 4.13 Canal cyst size in exc-1 (rh26) worms with or without pBK121.  
Diagramed using the data from Table 4.12 and Table 4.13.
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(Table4.12 and Table 4.13; Fig.4.12 and Fig.4.13).  It is possible that this gene is 
downstream of exc-9, so the mutants would not respond to the high level of 
EXC-9. 
 
4.7 Summary 
Injections of exc-9 into different exc background were done to find out the 
possible pathway for canal structure regulation. 
Injection of exc-9 into exc-4, exc-2, and sma-1 backgrounds could lengthen 
the canal, shrink the cysts in these mutants, and, sometimes, cause unextended 
canal as in wild-type worms.  In exc-1 and exc-5 mutant worms, no obvious 
changes have been seen. On the other hand, overexpression of exc-5 translational 
construct in exc-9 mutant worms could partial rescue exc-9 phenotype and 
sometimes cause unextended canal. All these indicate that exc-9 might work 
downstream of exc-2, exc-4 and sma-1, and works upstream of exc-5 and exc-1 to 
control the canal lumen formation (Summary in Table 4.14).   
 
4.8 A possible pathway that regulates the excretory canal structure 
sma-1 encodes βH-Spectrin to maintain apical structure of excretory canal 
(Praitis, V., Ciccone, E. et al. 2005). Since overexpressed exc-9 could partially 
rescue the phenotype of sma-1 mutants, it is possible there are other structural 
elements downstream of exc-9.  When sma-1 is missing, overexpression of 
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Table 4.14 Effects of overexpression exc-9 or exc-5 translational construct in other 
exc background. 
 
“+” means had positive effects. More symbol means stronger effects. 
“-” means  the construct had no effect. 
“?” means effect is not obvious. 
“\” means no base to judge.
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EXC-9 could upregulate these elements and help reinforce the apical surface of 
excretory canal. 
exc-4 is a chloride intracellular channel that might help to maintain the 
ionic concentration and pPH in the canal (Berry, K.L., Bulow, H.E. et al. 2003). 
Overexpression of exc-9 might be able to override the phenotype caused by exc-4 
mutation. 
exc-5 is a putative guanine nucleotide exchange factor(Gao, J., Estrada, L. 
et al. 2001; Suzuki, N., Buechner, M. et al. 2001).  The reciprocal experiments 
strongly support that exc-9 is upstream of exc-5. EXC-9 might help stabilize 
EXC-5 or help localization of EXC-5. 
exc-1 and exc-2 are two uncloned genes. The overexpression data suggest 
that exc-9 is downstream of exc-2 but upstream of exc-1. 
The EXC-9 protein works downstream of EXC-2 and EXC-4, but 
upstream of EXC-1, EXC-5 and CDC-42.  This pathway helps to localize 
SMA-1 protein to the apical surface of excretory canal.  When the worm has 
correct quantity of every protein in the canal, the canal can grow all the way to the 
tail and fine lumen of canal could be maintained properly.  If worm lost one of 
the components in the pathway, cysts formed in the lumen, and elongation of 
canal did not occor properly.  Having too much of one of the components will 
lead to proper formed apical surface, but the basal surface elongation got 
interrupted somehow and then form the unextended canal (Fig. 4.14).  
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All of these exc genes must work together to maintain the normal diameter 
of the excretory canal.  Since all exc mutants show some extend defects in the 
tail formation, the same pathway might also be involved in tail shape formation. 
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Figure 4.14. New model of exc genes regulate excretory canal structure.  The 
figure pictured part of the excretory tube.  Blue line stands for basal surface and 
red line stands for apical surface.  In between the blue lines is the canal tube, and in 
between the red lines is the lumen of the canal.  Blue arrow means suppress and red 
arrow indicates upregulate.  EXC-9 might work downstream of EXC-2 and EXC-4, 
but upstream of EXC-1, EXC-5 and CDC-42 to help localize SMA-1 to the apical 
surface of excretory canal to reinforce the structure.  EXC-9 might help other 
materials localize to the apical surface, thus it can partially rescue the sma-1 
phenotype.  The EXC-9 pathway also play a role in regulating outgrowth of basal 
membrane.  Overexpression of either EXC-5 or EXC-9 can prevent the outgrowth 
of basal membrane and causes unextended canal phenotype.  The pathway is also 
shown as flow chart at the bottome of the figure.
?
SMA-1
EXC-7
sma-1 mRNA
EXC-5
CDC-42
EXC-9
EXC-1
EXC-4
EXC-2
EXC-2 
EXC-4 
SMA-1 
 
EXC-9 
 
 
EXC-5 
EXC-1 
 75
 
 
 
 
 
 
 
 
Chapter 5 
Excretory canal-specific promoters 
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5.1 Excretory canal-specific promoter 
A promoter is a regulatory region of DNA that is normally located 
upstream of a gene.  The promoter is not directly responsible for the protein 
production level from a gene, but provides information as to when and where the 
gene should be transcribed.  Thus, it is important for the proper expression of the 
gene. It is possible that co-expressed genes share common regulatory elements.  
Identifying promoter elements for excretory canal expression will provide clues as 
to which genes are expressed in the canal. 
The excretory canal of C. elegans is a long tubular epithelial structure.  
The apical membrane of this tissue faces the lumen that connects to the outer 
environment for excretion.  The apical membrane organization depends on the 
proteins on the surface and in the cytoplasm.  It is probable that most of these 
proteins, if not all, are transcribed and translated in this cell.  In other words, 
most of the genes that control the apical structure of excretory canal are 
cell-autonomously.  Because of this, identifying which genes are expressed in the 
canal will give us a candidate pool for possible exc genes.   
Some of the excretory canal-specific promoter elements have been 
identified by Baillie’s group (Zhao, Z., Fang, L. et al. 2005).  In their work, three 
promoters were studied for the indispensable element for canal expression.  
These three genes did not show identical elements for expression regulation.  
One possibility is that there are more than three transcription factors that specify 
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the excretory canal, so the elements are distinct.  Alternatively, there might be 
some common domains in some of those elements.  Since many promoters have 
not been studied, it is difficult to rule out the possibility of common residues. 
During the current study of the exc genes, two new regions important for 
respective gene expression in the excretory canal that might contribute to the 
prediction of canal expression genes that have canal expression were identified. 
 
5.2 Promoter study of exc-9 
During the expression study of exc-9, worms expressing the pBK104 
construct (Pexc-9::gfp) showed a “lumpy-dumpy” phenotype at low percentage 
(<10%) (Fig.5.1, Table 5.1).  This is an embryonic lethality in which tissues form 
but fail to be shaped properly, and is found in mutants defective for ceh-6 which 
also is highly expressed in the canal (Burglin, T.R. and Ruvkun, G. 2001).  Most 
of the lumpy-dumpy worms caused by injection of Pexc-9:: gfp exhibited a high 
level of GFP expression.  In the transgenic line of pBK121 (exc-9::gfp), the 
similar phenotype and ratio was also observed.  Because the common sequences 
are the exc-9 promoter and the pPD95.75 backbone, one of these sequences must 
cause the lumpy-dumpy phenotype. 
To determine if this phenotype is caused by pPD95.75 backbone, two 
injections were done.  The constructs injected are similar to pBK104, and have 
the same pPD95.75 backbone, but with different promoter sequences.  The 
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Figure 5.1 “lumpy-dumpy” worms caused by injection of pBK104, the 
transcriptional construct of exc-9.  Anterior is to the left.  GFP expressed in the 
canal.  Buccal opening is clearly formed and gut granules are evident.  Scale bar: 
10 µm. 
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promoters are from genes B0496.7 and C03F11.1. For injections with these two 
constructs, none of the progeny with GFP expression showed the lumpy-dumpy 
phenotype (>3000 worms screened).  Because of these results, the pPD95.75 
backbone should not be the cause of the lumpy-dumpy phenotype. 
The exc-9 promoter then is the only possible cause for the lumpy-dumpy 
phenotype.  The lumpy-dumpy phenotype is also seen in ceh-6 mutants.  Since 
ceh-6 and exc-9 are expressed in the same tissue and similar phenotype has been 
observed, it is possible that there are links between these two genes.  A likely 
possibility is that CEH-6 is the transcriptional factor for exc-9, and a high copy 
number of the exc-9 promoter will lead to depletion of CEH-6, to result in similar 
phenotype as the ceh-6 mutant phenotype.   The other possibility is that the 
ceh-6 and exc-9 genes share common transcriptional factors.  Too many copies 
of exc-9 promoter will compete with the ceh-6 promoter for the transcriptional 
factors, and lead to low levels of CEH-6 produced.  In turn, some other vital 
genes that depend on CEH-6 will not be transcribed properly. 
To determine if the promoter of exc-9 was the reason for the lumpy-dumpy 
worms, three more new transcriptional vectors were made to examine the effect of 
various length promoters of exc-9.  The plasmid pPD95.75 was still used as the 
backbone for the vectors.  The 2.2 kb promoter includes the entire region 
between exc-9 and the next upstream gene. I divided this region into four pieces to 
make new transcriptional constructs.  The lengths of the new promoters are 0.7 
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kb, 1.4 kb and 1.8 kb, respectively to the start codon of exc-9. The structures of all 
transcriptional vectors are listed in Figure 5.2.   
For a stable line expressing construct pBK101 (with 0.7 Kb promoter), no 
canal GFP expression was detected.  The expression in intestine and neurons was 
not disrupted.  Similar to pBK104, the two constructs with larger promoter 
regions (1.4 Kb and 1.8 Kb) gave canal, UTSE, intestinal, and neuronal 
expression of GFP in the transgenic lines.  There are two noticeable differences 
between the stable lines with the three longest promoter constructs.   The first is 
that the N2 stable line with pBK102 (with 1.4 Kb promoter) showed weaker GFP 
expression level compared to the other two stable lines.  The second is that no 
lumpy-dumpy worms were found on plates of the stable line with pBK102 (See 
Table 5.1).   
One possible reason for the absence of lumpy-dumpy worms might be that 
there was less transcription of the injected construct in the stable line with 
pBK102.  With less transcription, the GFP production will be less and lead to 
lower visible fluorescence.  The reason of less transcribes might due to loss of 
the essential binding domain in the promoter since pBK102 has a shorter promoter 
compared to other constructs. 
As seen in Table 5.1, pBK103 caused less occurrence of the lumpy-dumpy 
phenotype than did pBK104.  It is possible that pBK104 could bind more 
transcriptional factors than did pBK103. 
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Figure 5.2 Structure of exc-9 transcriptional constructs with different length 
promoters.  The expression patterns are shown beneath the structure.  
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Neurons, intestine
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Table 5.1 Number of lumpy-dumpy worms found on the plate of stable lines with 
different exc-9 transcriptional constructs. 
There are about 300 worms on each plate 
.
Strain Vector Lumpy-dumpy worms 
N2 pBK104 17 
N2 pBK103 3 
N2 pBK102 0 
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Figure 5.3 Possible functions of different upstream regions of exc-9 promoter 
based on the study of expression pattern of exc-9 transcriptional constructs. 
Green boxes: promoter region of exc-9. Pink box: exons of GFP
1.4 kb
700bp2.2 kb
Drives neuronal, intestine expression
Drives canal expression
Possible enhancer region
1.8 kb
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Based on these results, several possible functional domains of exc-9 
promoter were predicted (Shown in Fig. 5.3).  The region between 0.7 kb and 1.4 
kb upstream of exc-9 is important for canal expression.  Without this part, the 
gene downstream will not be expressed in the canal or in other tissues in which 
exc-9 is normally expressed.  But the 700 bp region is still capable of driving 
neuronal and intestinal expression of the gene.  The next 400 bp upstream is 
important for stronger binding of transcriptional factors, and serves as an enhancer 
region.  With this part, the expression level of the gene will be upregulated.  But 
this expression also leads to the depletion of transcriptional factors from other 
genes.  The 400 bp farthest upstream contains some more binding sites for the 
transcriptional factors.  This is the reason that the stable line with pBK104 has 
the highest percentage of lumpy-dumpy worms. 
 
5.3 Elements crucial for vha-1 excretory canal expression 
When I made construct pBK130 (Pvha-1::exc-9::gfp), I used PCR to 
amplify the promoter region of vha-1 and then ligated the promoter into the 
revised vector.  Taq polymerase was used, so minor mistakes were introduced 
into the promoter.  It turned out that those minor mistakes did matter.  With 
these mistakes, the expression of GFP in the canal was interrupted. 
All the promoters sequenced from two independent amplifications had one 
common mistake a two-basepair substitution in 269 bp upstream of the 
endogenous start codon of vha-1.  It was a change of GC to TA.  The possible 
explanation is that the mistake exists in the original PCV01(Oka, T., Yamamoto, R. 
et al. 1997) vector, but didn’t interfere with the expression of GFP in the canal.  
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Because of this, I didn’t take this mistake into account for interruption of 
expression. 
One sequenced promoter with fewer mistakes was chosen for the new 
vector construct.  It has two additional mistakes other than the substitution 
mentioned before: one is a transition from A to G at –1024 bp, the other is a 
four-basepair deletion from –877 to –874 bp, the sequence GTTG in the promoter 
is deleted in the amplified new promoter.  The construct with this promoter 
sequence showed poor expression in the canal.  Among 50 glowing F1 progeny 
from injection, only 11 of them showed canal expression, a percentage of just 22%.  
As the deletion is closer to the start codon, and the sequence was affected more, I 
believe that the deletion is the main reason for the new expression pattern. 
In summary, the region around 870 bp upstream of the start codon is 
important for proper expression in the canal (Fig. 5.5).  Changes in this region 
will result in loss of gene expression in the canal. 
 
5.4 Summary 
The promoter regions of canal specific genes were analyzed to identify the 
key element for canal expression.  The two regions I found to be important for 
canal expression are not similar to the elements reported in previous work (Zhao, 
Z., Fang, L. et al. 2005), and nor does any similarity between these two regions 
exist. 
Additional work on the canal specific genes’ promoter will be useful to 
discover common control elements for canal expression. 
The phenotype caused by overexpression of exc-9 promoter suggests that 
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ceh-6 might be involved with exc-9 transcription.  Finding out whether exc-9 has 
normal expression pattern in ceh-6 mutant background will help us to determine 
whether exc-9 is transcribed by ceh-6 or these two genes share same 
transcriptional factors. 
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Chapter 6 
Study of the EXC-9 homologues 
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6.1 Tissue-specific expression of B0496.7  
As shown in Chapter 3, exc-9 has a close homologue in C. elegans, 
B0496.7.  To determine if this gene is expressed in the same tissue as is exc-9, 
the transcriptional construct pBK118 was created by fusing 1.1 kb upstream 
sequence of B0496.7 with the pPD95.75 backbone.  The construct was injected 
into wild-type worms and was expressed in different tissues than was the exc-9 
GFP transcriptional construct.  The construct is highly expressed in all the valves 
in the worm, including the pharyngeal-intestinal valve, the intestinal-rectal valve, 
and the spermatheca-uterine valve (Fig. 6.1).  In addition to the valves, GFP was 
also found in the gonadal sheath cell, seam cells, vulva muscle and some neurons 
including the PVD neuron (Fig. 6.1). 
Taken together, the B0496.7 reporter construct is expressed in different 
locations from exc-9 (See table 6.1 for comparison).  Most of the tissues with 
B0496.7 expression need to maintain accurate structure for proper function.  It is 
possible that these two genes function in similar pathways, but in different tissues 
because of the promoter difference. 
 
6.2 Phenotype of B0496.7 RNAi worms 
Since there is no knockout allele of B0496.7, RNAi was carried out to find 
out the knockdown phenotype of B0496.7.  dsRNA complementary to the coding 
region of B0496.7 was made.  Although the two gene products are similar in 
sequence, the DNA sequences of coding region vary from each other significantly.  
The dsRNA made should be only complementary to the B0496.7 mRNA but not to 
the exc-9 mRNA.  This dsRNA was introduced into wild-type worms by means 
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Figure 6.1 B0496.7 expression pattern. B0496.7 GFP reporter construct was found 
in several valve tissues including Pharyngeal-intestinal valve (indicated by white 
arrow in A), spermatheca-uterus (sp-ut) (B), and Rectal valve(C). The expression 
was also found in the seam cells (D) and gonadal sheath cells (E).  Scale bars, 25 
μm. 
C
D
E
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B
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Table 6.1 Comparison of expression of exc-9 and B0496.7 
Expression exc-9 B0496.7 
Excretory canal + - 
Tail spike + - 
Intestine + + 
UTSE + - 
Distal tip cell + - 
ALM neuron + - 
PLN neuron + - 
Seam cells - + 
Gonad sheath cell - + 
pharyngeal-intestinal valve - + 
intestine-rectal valve  - + 
spermatheca-uterine valve - + 
vulva muscle - + 
PVD neuron - + 
 
 
“+” means the expression of GFP was found in the corresponding tissues. 
 
“-” means the expression of GFP was not found in the corresponding tissues.
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of injection with pRF4 (rol-6) as marker. 
Three phenotypes were observed in the roller progeny (Fig.6.2).  The first 
one is the lack of bacteria in the intestine even when food is abundant.  This is 
likely due to the pharyngeal-intestinal valve was not being able to function 
properly, so the worms cannot eat.  The second phenotype is that in some worms, 
the eggs were trapped in the uterus after fertilization.  The reason might be that 
the spermatheca-uterine valve was not working.  The other phenotype is a 
defecation problem of the worms which might be caused by a intestinal-rectal 
valve problem.  These three phenotypes didn’t appear in all worms.  I repeated 
the injection 4 times, but only obtained 20 roller progeny, and all of them showed 
some extent of these defects.  The low number of progeny with marker suggests 
that knockout this gene is lethal to the worms.  Lethality may be the reason why 
no knockout allele has been isolated yet. 
dsRNA of B0496.7 was also injected into exc-9 (n2669) worms to see the 
phenotype.  No viable progeny with marker were observed from 200 injected P0 
animals.  Since knockdown of either of these two genes leads to sick worms, 
worms losing both genes might not be able to survive. 
 
6.3 Functional interchangeability of B0496.7 and EXC-9 
I speculated that exc-9 and the C. elegans homologue B0496.7 have 
similar function.  One proof is that both proteins bound to CSN-5 in the yeast 
two-hybrid assay.  The binding between B0496.7 and CSN-5 was shown 
previously by another group (Li, S., Armstrong, C.M. et al. 2004). 
The other thing I tried to determine was whether B0496.7 could rescue the
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Figure 6.2 B0496.7 RNAi phenotypes.  (A) Dying animal from RNAi injection.  
The worm did not have enough food, and interior began to degrade.  Anterior is to 
the right.  (B) An egg arrested in the spermatheca indicated by the white arrow.  
Anterior is to the left in this picture. 
A B 
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exc-9 phenotype when it is expressed in the same tissue as exc-9.  I showed in 
chapter 3 that EXC-9 is cell-autonomous, so that expression of B0496.7 only in 
the canal should be able to rescue exc-9 cystic canal phenotype if both genes have 
similar biochemical activity. 
A new construct, pBK123, was created similar as pBK122 
(Pvha-1::11aa::exc-9::gfp).  The only difference between these two constructs is 
the replacement of the exc-9 genomic coding region with the B0496.7 genomic 
coding region.  With this construct, the protein B0496.7 should be found mainly 
in the canal, and this protein will have eleven extra amino acids in the N-terminus. 
The plasmid pBK123 was introduced into exc-9 (gk395) worm by means 
of injection.  As we thought, the cystic canal phenotype of exc-9 was largely 
improved in the glowing progeny (Table 6.2, Fig. 6.3 and Fig. 6.4), but rescue was 
not as efficient as pBK122 injection.  This indicates that B0496.7 shares similar 
but not identical biochemical activity, or that the injections of pBK123 were less 
efficient. 
The plasmid pBK123 still has extra amino acids in the N-terminus.  
Without that part, B0496.7 might be able to give unextended canal phenotype as 
EXC-9 with a normal N-terminus.  This research will be carried out in the near 
future.  
 
6.4 Study of mouse CRIP 
Since B0496.7 could rescue the exc-9 cystic canal phenotype when 
expressed in the canals, we asked if the vertebrate homologues also are able to 
rescue exc-9.
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Table 6.2 Canal phenotype of F1 progeny of exc-9 (gk395) injected with pBK123 
(Pvha-1::11aa::B0496.7::gfp). 
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Figure 6.3 Canal ending point in exc-9 (gk395) worms with or without pBK122 
(Pvha-1::11aa::exc-9::gfp) or with pBK123 (Pvha-1::11aa::B0496.7::gfp).  Diagramed 
using the data from Table 3.1, Table 3.2, and Table 6.2.   
 
Figure 6.4 Canal cyst size in exc-9 (gk395) worms with or without pBK122 
(Pvha-1::11aa::exc-9::gfp) or with pBK123 (Pvha-1::11aa::B0496.7::gfp).  Diagramed 
using the data from Table 3.1, Table 3.2, and Table 6.2.
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       Compared to B0496.7, the amino acid sequence of mouse CRIP is more 
distant from that of EXC-9.  Three major differences were found between the 
amino acid sequences of mouse CRIP and EXC-9 (Fig. 6.5).  The first is that 
there is a shorter C-terminal tail in mouse CRIP.  The second is that there are two 
additional amino acids in the LIM domain of EXC-9.  The third one is that near 
the end of LIM domain, all vertebrate CRIP homologues have a proline, but none 
of the nematode homologues have it.  Since proline has a unique structure that 
alters protein secondary structure and breaks α-helixes, the presence or absence of 
proline could result in a different orientation of the rest of the protein.  The 
structural study of mouse CRIP already showed that the orientation of the 
C-terminus of this protein is different from that of CRP1 LIM domain, which has 
no proline in the corresponding place (Perez-Alvarado, G.C., Kosa, J.L. et al. 
1996). 
I made four constructs with different versions of the mouse CRIP coding 
region, as listed in Table 6.3.  The backbone used was still pCV01, which 
contains the vha-1 promoter linked to GFP, so the eleven amino acids on the 
N-terminus still existed. 
Some of the constructs were introduced into the exc-9 background 
separately to see whether any of them could rescue the cystic canal phenotype of 
exc-9 (Table 6.3-Table 6.6; Fig. 6.6-Fig. 6.9).   
Mouse CRIP by itself or with the addition of the nematode C-terminus did 
not rescue the cystic canal phenotype.  On the other hand, the construct that lacks 
the extra proline but with the nematode tail did partially rescue the cystic canal 
phenotype.  These results suggest that the proline does play a significant 
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Figure 6.5 Alignment of the CRIP proteins.  Major differences between nematode 
CRIP and vertebrate CRIP are indicated by black arrowhead.   
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Table 6.3 Coding regions in different mouse CRIP vectors. 
Plasmid name Coding region 
pBK131 Mouse CRIP cDNA 
pBK132 Mouse CRIP cDNA in frame with nematode C-terminus 
pBK133 Mouse CRIP cDNA in frame with nematode C-terminus, without 
extra proline 
pBK134 Mouse CRIP cDNA in frame with nematode C-terminus, with two 
additional nematode amino acids in LIM domain 
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Table 6.4 Canal phenotype of F1 progeny of exc-9 (n2669) injected with pBK131 
(Pvha-1::11aa::mouse CRIP::gfp). 
 
 
 
 
 
Table 6.5 Canal phenotype of F1 progeny of exc-9 (n2669) injected with pBK132 
(Pvha-1::11aa:: mouse CRIP+tail::gfp). 
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Figure 6.6 Canal ending point in exc-9 (n2669) worms with or without pBK131 
(Pvha-1::11aa:: mouse CRIP::gfp)  or pBK132 (Pvha-1::11aa:: mouse CRIP+tail::gfp).  
Diagramed using the data from Table 3.3, Table 6.4, and Table 6.5. 
 
Figure 6.7 Canal cyst size in exc-9 (n2669) worms with or without pBK131 (Pvha-1::11aa:: 
mouse CRIP::gfp)  or pBK132 (Pvha-1::11aa:: mouse CRIP+tail::gfp).  Diagramed 
using the data from Table 3.3, Table 6.4, and Table 6.5. 
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Table 6.6 Canal phenotype of F1 progeny of exc-9 (gk395) worms injected with 
pBK133 (Pvha-1::11aa:: mouse CRIP+tail+pro::gfp). 
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Figure 6.8 Canal ending point in exc-9 (gk395) worms with or without pBK133 
(Pvha-1::11aa:: mouse CRIP+tail+pro::gfp).  Diagramed using the data from 
Table 3.1 and Table 6.6. 
 
Figure 6.9 Canal cyst size in exc-9 (gk395) worms with or without pBK133 
(Pvha-1::11aa:: mouse CRIP+tail+pro::gfp).  Diagramed using the data from 
Table 3.1 and Table 6.6.
VC976 canal length
0
10%
20%
30%
40%
50%
60%
70%
80%
90%
cell body <vulva around Vulva >vulva full length Unextended canal
canal length
pe
rc
en
ta
ge
VC976 worm(n=119)
VC976 with pBK133 (n=68)
pe
rc
en
ta
ge
VC976 cyst size
0
10%
20%
30%
40%
50%
60%
70%
80%
90%
L M S N 
cyst size
pe
rc
en
ta
ge
VC976(n=119)
VC976 with pBK133 (n=64)
pe
rc
en
ta
ge
 103
functional role in the protein conformation.  With or without this residue, the 
angle between the C-terminus and the LIM domain will be different.  As a result, 
the orientation of any binding partners will likely be different as well.  Since all 
these constructs have the extra amino acids on the N-terminus, the results did not 
preclude the possibility that with a free N-terminus, the mouse CRIP could cause 
the same unextended canal phenotype as EXC-9. 
 
6.5 Summary 
By studying the function of the homologues in the excretory canal, I 
determined that B0496.7 not only shares similar sequence but also similar 
function as does EXC-9.  These two proteins function in distinct locations to 
fulfill a similar function. 
The mouse CRIP failed to rescue the cystic canal phenotype when 
introduced into the excretory canal cell.  After modification, partial rescue was 
observed.  The lack of rescue by mouse CRIP might be due to the additional 
proline in the vertebrate CRIP, which alters the relative orientation of the LIM 
domain and the C-terminus tail, and then change the protein conformation.  
Without this proline, the mouse CRIP could function similarly to EXC-9 as well. 
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Chapter 7 
exc-2 cloning  
 105
7.1 exc-2 mutant 
exc-2 is a recessive mutant with excretory canal defects similar to but more 
sever than those of exc-9.  The canal phenotype is the main defect of exc-2 (Fig. 
7.1).    44% of exc-2 mutants show cysts that large enough to be visible under 
the dissecting microscope.  In some of the exc-2 worms, because the abnormal 
canal structure interferes with the normal function of the canal, they are unable to 
get rid of liquid waste.  As a result, variable amounts of lethality can be observed 
at all larval stages on exc-2 plates. 
Similarly to exc-9, exc-2 mutants also show tail defects in both 
hermaphrodites and males. 
exc-2 is located on chromosome X.  It was mapped between dpy-8 and 
mec-2 previously (Buechner, M., Hall, D.H. et al. 1999).  Since it was shown that 
exc-9 overexpression can partially rescue exc-2, knowing the identity of exc-2 will 
help us to understand the pathway that regulates the apical membrane organization 
of excretory canal. 
 
7.2 Does C03F11.1 encode exc-2? 
exc-2 was previously thought to be encoded by C03F11.1, a gene that 
encodes a small conductance calcium-activated potassium channel protein, based 
on RNAi results and one sequencing result.  But no rescue attempt was carried 
out at that time (done by Kelly Homb).   
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Figure 7.1 exc-2 canal phenotype.  This is a worm has better canal 
phenotype compare to most of the exc-2 mutants.  The head of the 
worm is to the right in this picture.  Scale bar: 50µm 
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To test this result, several approaches were carried out.  The first 
was to redo the RNAi experiment.  The previous RNAi injection was done using 
pCV01 as injection marker.  To ensure that the maker wouldn’t interfere with the 
RNAi result, I used the marker pRF4 instead.  31 roller worms were found from 
injection, but none of them showed canal defect.  The phenotype observed before 
might be caused by pCV01 instead of dsRNA of C03F11 since it has been shown 
that the pCV01 construct can interfere with canal structure.  The second thing is 
to confirm the mutation in the gene.  The gene C03F11.1 from exc-2 mutant rh90 
was amplified three times for sequencing of the mutation.  It turned out that none 
of the amplifications had the stop codon that the previous sequencing showed, and 
no other mutations have been found.  The previous mistake could have been 
introduced by PCR.  I also tried the rescue experiment to see whether the gene 
C03F11.1 encodes exc-2.  I used different DNA constructs, including cosmid, 
and HindIII digestion fragments including C03F11.1 and C03F11.1 PCR products, 
to rescue the exc-2 mutant phenotype.  More than 15 progeny expressing the 
pRF4 were isolated from each injection, but none of them showed improved 
canals.  The final thing I tried was to find out the expression pattern of C03F11.1.  
A transcriptional construct was made using the C03F11.1 promoter followed by 
the GFP coding region.  It turned out that the GFP is highly expressed in the head 
neurons, but not in the excretory canals (Fig. 7.2).  In sum, it is unlikely that 
C03F11.1 is the gene that encodes exc-2.   
 
7.3 SK3 channel study 
During the study of C03F11.1, we wondered whether the failure of the 
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Figure 7.2 Expression of C03F11.1 reporter construct in ADF neuron, a amphid 
neuron. Scale bar: 10µm 
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RNAi experiment was due to redundant function of the homologues.  In 
addition to C03F11.1, there are three other SK3 homologues in C. elegans.  They 
are B0399.1, C53A5.5, and F08A10.1.  They are members of the small 
conductance calcium-activated potassium channel group.  The hypothesis was 
that this kind of potassium channel might function with EXC-4, a chloride 
intracellular channel (Berry, K.L., Bulow, H.E. et al. 2003), to regulate the ionic 
strength in the canal.   
I did RNAi experiments on single genes and also combined four dsRNAs 
for injection to see the phenotype.  More than ten progeny expressing the pRF4 
were found from each injection, but none of them gave similar canal phenotype as 
found in exc-2 animals.  Some subtle effects were observed from one injection of 
B0399.1 dsRNA injection (Table 7.1).  Those injection progeny displayed a 
pharynx-pumping defect.  Most of the time, the pumping is at the same rate as in 
wild-type worms.  But in affected progeny, the pharynx sometimes stops for a 
long time (usually longer than 30 seconds) and then resumes as normal.  A 
similar phenotype was also observed in the knock-out strain of this gene. 
It is possible that there are some other defects that I didn’t notice.   
 
7.4 RNAi screen for exc-2 
Since the region in between dpy-8 and mec-2 is not too huge, I choose to 
do RNAi on every single gene in the region to find out exc-2.  pBK104  
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Table 7.1 RNAi phenotype of the possible exc-2 genes.  The order of the genes in 
the table is according to the injection order. 
 
Gene Canal defect Other noticeable defect 
C03F11.1 No No 
B0399.1 No Slow pharynx pumping 
T03G11.2 No No 
T03G11.8 No No 
Y34B4A.4 No No 
C25F6.4 No No 
T03G11.1 No No 
T03G11.3 No No 
T03G11.4 No No 
T03G11.5 No No 
T03G11.6 No No 
C31H2.3 No No 
C31H2.4 No No 
H28G03.6 No No 
C41A3.2a No No 
Y34B4A.2 No No 
Y34B4A.3 No No 
Y34B4A.5 No No 
Y34B4A.6 No No 
Y34B4A.7 No No 
Y34B4A.8 No No 
Y34B4A.9 No No 
Y34B4A.10 No No 
F32A6.3 No Dead glowing eggs 
C41A3.2B No No 
C41A3.2 No No 
C41A3.1 No No 
C25F6.7 No No 
C25F6.6 No No 
C25F6.3 No No 
C25F6.2 No Dead glowing eggs 
C25F6.1 No No 
F55D1.1 No No 
F55D1.2 No No 
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C54G7.1 No No 
C54G7.2 No No 
C54G7.3 No No 
C54G7.4 No No 
T23F2.1 No Some unc progeny 
H28G03.1 No No 
H28G03.3 No No 
F35C8.1 No No 
F35C8.2 No No 
T23F2.2 No No 
EGAP5.1 No No 
H28G03.2 No No 
H28G03.4 No No 
F32A6.2 No No 
F32A6.1 No No 
F32A6.5 No No 
C26B9.5 No No 
C26B9.3 No No 
C26B9.2 No No 
C26B9.1 No No 
C26B9.7 No No 
C26B9.6 No No 
F35C8.4 No No 
F35C8.6 No No 
F35C8.7 No No 
F35C8.5 No No 
F35C8.3 No No 
F35C8.8 No No 
C03F11.2 No No 
C03F11.3 No No 
C03F11.4 No No 
T23F2.3 No No 
T23F2.4 No No 
T23F2.5 No No 
C38C5.1 No No 
C53A5.5  No No 
F08A10.1 No No 
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(Pexc-9::gfp) was used as injection marker since it can label the excretory canal.  
More than ten progeny showing the GFP expression in canal were screened from 
every injection for the canal phenotype.  The results are listed in Table 7.1.  As 
shown in the table, none of the injections yielded progeny with cystic canals as 
did exc-2 mutants.  There are two plausible reasons.  One is that the dsRNA 
design was not specific enough to break down the mRNA.  The other possibility 
is that the region does not include exc-2. 
 
7.5 SNP mapping of exc-2 
SNP mapping was chosen to narrow down the region of exc-2.  dpy-8 was 
used as left marker for SNP mapping.  A single Dpy-8 non-Exc-2 recombinant 
was isolated from the cross and its homozygous Dpa-8 non Exc-2 progeny were 
subjected to SNP sites testing.  The chromosome to the left side of the 
recombination site should have the same pattern as N2 worms, and to the right 
side of the recombination break point should have the CB4856 pattern.  Based on 
the digestion result of SNP site C54G7: 22992 (Table7.2, Fig. 7.3), which is the 
same pattern as N2 digestion pattern, it should be to the left of recombination site, 
and in turn to the left of exc-2.  There are only three genes in between this 
position and mec-2 location.   
Some of the primers for dsRNA complementary to these three genes were 
remade, aiming to amplify a larger region and knock down the mRNA more 
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efficiently.  RNAi experiments were done to knock down these three genes.  It 
turned out that none of these RNAi experiments gave cystic canal progeny. 
The SNP sites downstream of this site were tested for the digestion pattern.  
The digestion pattern showed that mec-2 is not the boundary of exc-2 (Table7.2, 
Fig. 7.3).  exc-2 should locate to the right of mec-2 . 
More recombinants are required to further narrow down the region of 
exc-2.   
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SNP site comments 
C54G7:22992 N2 Digestion pattern 
F14D12 :39094 PCR didn’t work 
T21F4:13904 N2 Digestion pattern 
W01C8:26415 Digestion didn’t work 
C54H2:23555 N2 Digestion pattern 
F13D11:6838 CB4856 Digestion pattern 
 
Table7.2 exc-2 SNP mapping data. 
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Figure 7.3 Schematic drawing of the Dpy non-Unc recombinant chromosome and 
SNP sites in the region.  Black arrows point to the tested SNP sites position in 
the cosmid.  SNP sites on cosmid C54G7, T21F4, and C54H2 turned out to have 
the same digestion pattern as N2 worms, they should be to the left of exc-2.  SNP 
site on cosmid F13D11 showed same digestion pattern as CB4856.  exc-2 should 
be to the right of SNP site C54H2:23555, but to the left of unc-6. 
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Chapter 8 
Conclusion and future directions 
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This thesis reports the cloning and characterization of exc-9.  I showed 
that a novel single-LIM-domain protein is required for apical membrane 
maintenance of the shape of the excretory canals.  In this chapter, I will discuss 
the implications from these results and also discuss the future experiments that 
could be done to better understand EXC-9 function and the pathway(s) that 
regulates the excretory canal apical organization.  
 
8.1 C. elegans CRIP homologue is required for tubulogenesis 
The exc-9 mutant is the first CRIP mutant available for study.  In this 
report, I demonstrate that EXC-9 is required to help maintain the apical 
cytoskeletal strutcture of the excretory canals.  EXC-9 is located in the 
cytoplasm of the excretory canal tubes and the presence of EXC-9 in the canal is 
required and sufficient to maintain the apical structure of the excretory canal.  
How EXC-9 functions to maintain the tubular structure is not clear, but it likely 
functions by binding with other proteins.  Overexpression of EXC-9 with an 
unblocked LIM N-terminus can lead to “unextended” canals, and that his 
phenotype might be due to the exposure of the LIM domain binding site to the 
partners.   
  These data provide information of CRIP function in vivo.  It will be 
interesting to determine if the function of vertebrate homologues is conserved in 
similar developmental events.  Since vertebrate homologues are located in the 
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intestine and heart, which also have tubular structures, the pathway in which 
EXC-9 functions might be conserved in vertebrates as well.  
It is proposed that LIM-only proteins function by binding with other 
proteins (Kadrmas, J.L. and Beckerle, M.C. 2004).  To prove that EXC-9 does 
work by binding with other proteins, some more experiments are required.  The 
yeast two-hybrid experiment has been done, but we don’t think that CSN-5 is a 
binding partner of EXC-9 in vivo since they have distinct expression pattern and 
don’t show similar phenotype in the mutants.  After a better antibody is acquired, 
immunoprecipitation will be a good experiment to try for finding binding partners 
of EXC-9. 
 
8.2 The pathway that regulates the apical membrane organization in excretory 
canal 
Since overexpression of EXC-9 causes unextended canal in wild-type and 
exc-9 mutant backgrounds, I carried out injections of exc-9 translational construct 
into different exc backgrounds to rule out a possible pathway that regulates the 
excretory canal apical membrane.  Overexpression of EXC-9 can partially rescue 
exc-2, exc-4, and sma-1 mutants, and cause unextended canal, but failed to rescue 
exc-1 and exc-5 mutants.  Overexpression of EXC-5 causes unextended canal 
phenotype in exc-9 mutants. 
Based on these rescue data, it is possible that EXC-9 functions 
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downstream of EXC-2 and EXC-4, but upstream of EXC-1, EXC-5 and CDC-42 
to organize the apical membrane of the excretory canal (See Fig. 4.14 for detail). 
Since I only have the reciprocal rescue data for EXC-5 and EXC-9, it is 
possible that other genes are in parallel pathways that regulate canal structure.  
Cloning projects of exc-1 and exc-2 are being carried out in the lab now. The 
cloning data of these genes will be important for the reciprocal rescue results later.   
 
8.3 Functional interchangeability of C.elegans CRIP proteins 
As described, B0496.7 rescues the exc-9 cystic canal phenotype when 
ectopically expressed in the C. elegans excretory canals.  Thus, these two C. 
elegans CRIP homologues function in a similar way.  Mouse CRIP cannot rescue 
the exc-9 canal phenotype directly, but after modification, it can rescue the 
phenotype as well.  It is possible that mouse CRIP still functions in a similar way 
as does EXC-9, but because of the conformation changes of the binding partners, 
the structure of mouse CRIP is slightly different from that of EXC-9.  With the 
addition of nematode specific C-terminus and without the additional vertebrate 
specific proline, the conformations of mouse CRIP is similar to that of EXC-9. 
Structural work of EXC-9 will help to find out the exact differences 
between EXC-9 and mouse CRIP.  We can do either NMR or crystallography to 
solve the structure of EXC-9, or do the threading to fit the EXC-9 sequence with 
mouse CRIP tertiary structure. 
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8.4 Screens for suppressor allele 
Finding suppressors of EXC-9 will help us to better understand the 
pathway that regulates the canal structure. 
Overexpression of EXC-9 causes the unextended canal in wild-type and in 
some exc mutant backgrounds.  In one stable line of exc-4 (rh133) with pBK121, 
the exc-9 translational construct, almost 100% of glowing worms have unextended 
canals.  If we can integrate the extrachromosomal array into the chromosome, we 
could use this allele for screening of EXC-9 suppressors.  The suppressor should 
be able to make the glowing worms have longer canal or even cystic canal even in 
the presence of the pBK121 construct. 
By doing this, we might be able to find more genes in the same or relevant 
pathway as exc-9.   
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Chapter 9 
Materials and Methods 
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Worm Culture 
Most worms were grown at 20°C using standard conditions (Sulston, J.E. 
and Hodgkin, J. 1988).  Worms with fem-3 mutation are sterile at high 
temperature (Hodgkin, J.A. 1986).  The original fem-3 strain was kept at 15°C; 
heterozygous fem-3 exc-9 double mutants over Hawaiian chromosome were kept 
at 25°C to get exc-9-non-fem-3 recombinants. 
The wild-type strains were Bristol N2 and Hawaiian CB4856.  Other 
strains includs: 
LG I: NJ469 exc-4 (rh133)  
BK36 unc-119(ed3); qpIs11[unc-119;Pvha-1::gfp]. 
LG IV: MT6984 exc-9 (n2669) 
VC961 exc-9 (gk395)  
BK9 bli-6 (sc16) exc-9 (n2669)  
BK39 exc-9 (n2669) fem-3 (q22)  
BK41 exc-9 (n2669) unc-5 (e53)  
CB3824 eDf19/unc-24 (e138) dpy-20 (e1282);  
NJ731 exc-5 (rh232);  
VC861 csn-5(ok1064) IV/nT1[qIs51] (IV;V). 
LG V: AZ30 sma-1 (ru18)  
DR466 him-5 (e1490) 
LG X: NJ51 exc-1 (rh26) 
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 NJ242 exc-2 (rh90).  
CB4856 was a gift from Dr. Lisa Timmons. VC961, VC861 and JK551 
fem-3 (q22) unc-5 (e53) were obtained from the CGC (University of Minnesota). 
 
SNP mapping  
SNP, single-nucleotide polymorphism, mapping is based on the basepair 
differences between two wild-type alleles.  When a double-mutant in the N2 
background is crossed with a CB4856 wild type, recombinations will happen in 
the heterozygous F1 progeny (Fig.9.1).  As seen in the figure, the chromosome to 
the left of the recombination site is the same as N2 chromosome, and the one to 
the right is the same as CB4856.  If we can determine that one SNP site is the 
same pattern as N2, it should be to the left of the recombination site, then it has to 
be to the left of the unc gene. 
CB4856 male line was obtained by picking spontaneous males onto new 
plates for crossing.   
For the SNP mapping on the left side of exc-9, CB4856 males were 
crossed to BK9 (bli-6 (sc16) exc-9 (n2669)) hermaphrodites.  bli-6 exc-9/CB4856 
worms were isolated in the F1 generation.  These worms are wild-type, as 
compared to the homozygous blistering self-progeny of the hermaphrodites.  
Since bli-6 mutations are not 100% penetrant, all these worms were checked via 
DIC microscopy to make sure that the canals appeared wild-type.  For the F2 and 
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later generations, I still kept the wild-type heterozygous worms for later isolation 
of recombinants.  I screened the progeny for worms with blister phenotype but 
no canal defect.  After letting the recombinants self-fertilize, I got the 
homozygous recombinants, and analyzed the progeny of the recombinants by 
means of single-worm PCR/restriction digestion for the SNP sites in between bli-6 
and fem-3 (See Figure 9.1 for details).  SNP sites with differences in sequence at 
restriction sites in either N2 or CB4856 worms were chosen to be tested.  SNPs 
examined and primers used for amplification are listed in Table 9.1.  Information 
regarding the location of the polymorphism and digestion pattern was found at the 
following site: 
http://genome.wustl.edu/genome/celegans/celegans_snp.cgi 
For the SNP mapping to the right side of exc-9, similar strategy was used.  
exc-9 fem-3/CB4856 worms were picked from a cross of CB4856 males and exc-9 
fem-3 hermaphrodites, and maintained at 15°C.  The heterozygotes then were 
kept at 25°C to produce progeny.  All homozygous fem-3 worms will be sterile at 
this temperature.  Only heterozygotes, segregating CB4856 and Exc-9 
non-Fem-3 worms, will be able to produce progeny.  The worms with eggs were 
picked out to be examined for their canal phenotype.  The ones with abnormal 
canals are the exc-9-non-fem-3 worms, and were kept to get homozygous progeny 
and then analyzed for SNP sites (Fig. 9.3).  The SNP site information is listed in 
Table 9.2. 
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 Figure 9.1 Schematic drawing shows how SNP mapping works. 
dpy AT       GAT    unc T
+          ACT        GT      +       G
Pick Dpy non-Unc homozygotes
dpy ACT GT +  G dpy AT GT +  G dpy AT GAT +  G
CB4856
Recombinant #1 Recombinant #2 Recombinant #3
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Figure 9.2 Strategy used for exc-9 SNP mapping on the left side. 
 
 
 
 
 
 
 
F3 
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Table 9.1 Primers used for SNP mapping of exc-9 from left side.   
The enzyme used for digestion, and the strain whose DNA is cut by the enzyme 
are listed in the table. 
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Figure 9.2 Strategy used for exc-9 SNP mapping on the right side. 
 
 
 
25°C 
Self progeny Cross progeny 
F3 
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Table 9.2 Primers used for SNP mapping of exc-9 from the right side.   
The enzyme used for digestion, and the strain whose DNA is cut by the enzyme 
are listed in the table
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SNP mapping of exc-2 was done in a similar way as for exc-9, dpy-8 was 
selected as the marker on the left side.  The primers used for exc-2 SNP mapping 
are listed in Table 9.3. 
 
Cosmid rescue 
Bacteria containing cosmids in the region between cosmid C06A6 and 
B0218 were obtained from the Sanger center (http://www.sanger.ac.uk/).  They 
were grown in the appropriate selective medium (KanR or AmpR).  Cosmid DNA 
was isolated using the DNA prep protocol.  After purification, the cosmids were 
digested using restriction enzyme and fragments analyzed via gel electrophoresis 
to make sure that the cosmid structure is intact.  After confirmation that the 
cosmid is intact, exc-9 worms were injected with the cosmid at the concentration 
of 100µg/ml in water.  Plasmid pCV01 was used as co-injection marker.  Worm 
injections were performed using standard techniques (Mello, C. and Fire, A. 1995).  
Injection mothers were let recover for several hours before transfer onto fresh 
seeded plates.  Progeny with glowing canals were examined under fluorescent 
dissecting microscope.   
   
Digestion fragment and Single gene rescue  
To prove that F20D12.5 is the gene encoding exc-9, two rescue injections 
were done. 
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Table 9.3 Primers used for SNP mapping of exc-2.   
 
 
The enzyme used for digestion, and the strain whose DNA is cut by the enzyme 
are listed in the table.
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Cosmid F20D12 was digested using FspI into 3 pieces.  The digestion 
fragments were run on a 1% crystal violet agarose gel (followed Invitrogen 
reagent instruction) and then the 11kb fragment was purified using Wizard® SV 
gel and PCR Clean-up system (Promega, Madison, WI). The 11Kb fragment 
contained the predicted exc-9 gene and the 2.2kb region between exc-9 and the 
next gene upstream.  The exc-9 gene was also PCR-amplified from N2 genomic 
DNA to get the 2.2kb upstream region plus the predicted coding region.  These 
two DNA fragments were injected into exc-9 (n2669) mutants separately.  pRF4 
was used as co-injection marker. 
 
RNAi  
dsRNAs were synthesized for the genes of interest.  The fragments 
complementary to the coding region of the gene were amplified by means of PCR 
first.  All the primers for amplification have the T7 promoter at the 5’ end.  The 
dsRNAs were made using MEGAscript® kit from Ambion (Ausin, Texas).  The 
synthesized dsRNA was used directly for injection with co-injection marker. 
The injection progeny with marker were screened for abnormal canal 
phenotype. 
The primers used for dsRNA synthesis for exc-9 and exc-2 are listed in Table 9.4 and 
Table 9.5. 
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Sequencing of mutant allele 
Genomic DNA was isolated from exc-9 (2669) mutants by use of DNA 
prep protocol.  The predicted gene region was amplified by use of PCR and then 
ligated into TOPO® TA cloning vector (Invitrogen, Carlsbad, CA).  Every colony 
from the transformation plate with a positive insert has a different clone of PCR 
product.  We purified DNA from 8 colonies derived from two independent PCR 
reactions and ligation/ transformation reactions.  DNA sequencing of the 
amplified region was performed on both strands. All sequencing reactions were 
done by Idaho State University Molecular Research Core Facility (ISU MRCF). 
 
5’ RACE and 3’RACE 
To find out the ends of exc-9, 5’RACE and 3’RACE were performed.  
mRNA was purified from N2 worms.  The experiments were done following 
manufacturer’s instructions; kits for RT-PCR and RACE are from Invitrogen, 
Calsbad, CA.  The primers used are listed in Table 9.6 and Table 9.7. 
 
Complementation test 
Homozygous gk395 males were obtained from mating N2 males with 
VC961 hermaphrodites and back-crossing the heterozygous F1 males to VC961.  
The gk395 males were then crossed with BK41 exc-9 (n2669) unc-5 (e53), to 
make cross progenys.  The male cross-progeny were screened for canal  
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Table 9.4 RNAi primers used to synthesize dsRNA to test as apossible exc-9 gene. 
*All the RNAi primers have T7 promoter region at the 5’ end.  
Sequence: 5’- GAT AAT ACG ACT CAC TAT AGG G-3' 
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Table 9.5 RNAi primers used to synthesize dsRNA to test as a possible exc-2 gene 
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*All the RNAi primers have T7 promoter region at the 5’ end.   
Sequence: 5’- GAT AAT ACG ACT CAC TAT AGG G-3' 
The primers are listed in the order that the corresponding dsRNA was injected.
 137
phenotype, and all of them showed abnormal canals. 
 
Mapping of BK36 
Strain BK36 has an integrated array in the chromosome.  Knowing the 
location of this array will make future crosses easier.  BK36 males were mated 
with available marker strains of different chromosomes.  It turned out that the 
array is located on LG I (See Table 9.8 for details of the crosses). 
 
Plasmid construction 
All the inserts were amplified via PCR using Taq or Pfu polymerase.  The 
inserts were ligated into pCR®-XL-TOPO® vector (Invitrogen, Carlsbad, CA) first 
for optimal yield.  The inserts were then digested out from the vector by use of 
corresponding restriction enzymes; and purified after running on acrystal violet 
gel using using Wizard® SV gel and PCR Clean-up system (Promega, Madison, 
WI). 
For all the constructs with pPD95.75 as backbone, the inserts were ligated 
into PstI and HindIII cutting sites.  MscI and SacI sites were used to ligate inserts 
into the pCV01 backbone.  EarI enzyme was used to modify the mouse CRIP 
sequence.  Since the EarI recognition site will be cleft off after digestion, no new 
sequence will be introduced into the new constructs because of EarI.  Plasmid 
pBK121 was sequenced to make sure that no mistake was made during the PCR  
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Table 9.6 Primers used for 5’RACE. 
 
Table 9.7 Primers used for 3’RACE. 
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Table 9.8 Results of BK36 linkage crosses to markers on different chromosomes. 
The array is linked to dpy-5 unc-13 on LGI. 
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reaction. 
The plasmids are listed in Table 9.9.  The primers used for amplification 
and sequencing are listed in Table 9.10. 
 
Classification of exc phenotype and plotting 
I divided the canal cyst size into five categories: none (N), tiny (T), small 
(S), medium (M) and large (L). “None” stands for a perfect canal with no cysts.  
Canals with some slightly wide regions were termed as canals with tiny cysts.  
When the cyst diameter was smaller than one quarter of the worm diameter, we 
called it a “small” cyst; when it is larger than one quarter of the worm diameter, 
but smaller than half the worm diameter, it is classified as “medium” size cyst; 
when the cyst diameter is larger than half of the worm diameter, it is termed as a 
“large” cyst.   
For the canal length, five categories were used.  “Cell body” means the 
canal didn’t extend to the posterior at all, or slightly. “<vulva” represents the canal 
length in between cell body and vulva, which is located in the middle of the 
animal.  Canals extending to the area close to the vulva are classified as “around 
vulva”.  If canals extended past the vulva but did not reach the full length, they 
are called “>vulva”.  Only the canals that went all the way near the tail are called 
“full length”. 
In this report, I record the canal phenotype according to these categories. 
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Table 9.9 List of all the constructs used in the study.   
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Table 9.10 Primers used for amplification and sequencing for the construction 
of the plasmids. 
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The “unextended canal” will be “none” for cyst, and “cell body” for canal length. 
When I plotted the diagram, I combined the tiny and small categories.  
And since the two tubes of the left and right excretory canals are two independent 
events, the number refers to the canal number instead of worm number.  For the 
canal length diagrams, “cell body” is close to the intersection, and “full length” is 
far away.  So the further away from X, Y axis intersection, the closer the canal 
length phenotype is to wild-type.  This also applies to the diagrams of cyst size 
that have “large (L)” close to the intersection and “none (N)” far from 
intersection. 
 
Alignment of EXC-9 protein sequence with that of homologues 
Alignment is done on http://www.ebi.ac.uk/clustalw/ as described (Chenna, 
R., Sugawara, H. et al. 2003). 
 
Primers used for B0496.7 RNAi 
5’Primer: 5' - TAATACCACTCACTATAGGGTAAGTTGTTTTTTCAAGTT - 3' 
3’ Primer: 5' - TAATACCACTCACTATAGGTTTCCAGTAGTTCCTTGA - 3' 
 
Western blot and protein detection. 
SDS/PAGE was performed following standard protocol, using pre-made 
NupageTM 4-12% Bis-Tris gel (1.0mmX10well) (Invitrogen) and XCell 
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SureLockTM gel box (Invitrogen).  
For each lane, 30μg of sample was loaded.  Kaleidoscope Prestained 
Standards (Bio-rad) was loaded and run along with protein samples as marker.  
Protein bands were transferred from gel to PVDF membrane (Millipore) 
(presoaked in methanol followed by transfer buffer) by electrophoresis at 150mA 
for 4 hours.  The presence of the transferred protein was estimated by 
visualization of the rainbow marker on the membrane.  
Immediately after transfer, the membrane was blocked in blocking buffer 
(5% nonfat milk in 1XPBS) for overnight at room temp, then incubated with either 
purified 14650/14651 immunized serum or 14650/14651 preimmune serum 
(1:1000 dilution) in blocking buffer overnight, washed with blocking buffer four 
times, each time 5 minutes, followed by the incubation with secondary 
fluorescein-conjugated goat anti rabbit IgG (1:10000 dilution, ICN biomedicals, 
Inc. Aurora, OH) for 1 hr at room temp,   followed by four 5 minutes PBS-tween 
washes. 
The immunoreactive bands were detected by ECLTM Western blotting 
detection reagents (Amershan Biosciences, UK) and protein bands were visualized 
from 13x18cm individually wrapped films by autoradiography. 
 
Cell identification 
GFP-positive cells were identified according to their position and 
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morphology (www.wormatlas.org; Sulston, J.E. and Horvitz, H.R. 1977). 
 
Microscopy 
Worms and embryos were observed by placing them on 2% agarose pads 
in M9 buffer with 1% 1-phenoxy-2-propanol added.  For observation of active 
worms, 1-phenoxy-2-propanol was omitted. DIC and/or fluorescence microscopy 
were done (Sulston, J.E. and Hodgkin, J. 1988) with a Zeiss Axioskop Microscope 
and photographed with a MagnaFire Electronic Camera (Optronics).  The images 
were assembled with Corel Photopaint. 
 
Single-worm PCR 
 
DNA from the recombinant progeny for SNP mapping was examined by 
use of single-worm PCR. To be sure, five worms were used for reaction instead of 
one. 
 
Preparation for the PCR: 
Put 13.5µl water into Eppendorf® tube, and pick 5 worms in to this liquid 
Freeze in –80 °C freezer for 10 min 
Thaw at room temperature 
Add 1.5µl lysis solution (proteinase K included), vortex 
Freeze in –80 °C freezer for 10 min again 
65°C incubation 60 min (proteinase K digestion) 
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95°C incubation 10 min (inactivation of proteinase K) 
Spin for 1 min and take supernatant for PCR reaction 
 
PCR cycle 
 
 
 
Step 
No. 
Cycle temperature Cycle time Repeat 
1 92°C 2min 1 cycle 
2 92°C 35sec  
3 50°C -60°C depends on 
annealing temperature 
35sec  
4 72°C 1min/kb of 
expected product 
length 
Go back to step 
2 39 times 
5 72°C 10min 1 cycle 
6 4°C Forever 1 cycle 
 
Worm lysis solution: 
100mM Tris (PH 8.5) 
100mM NaCl 
50mM EDTA 
1% SDS 
1% β-mercaptoethanol 
100µg/ml proteinase K 
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